0001213900-21-037022.txt : 20210715 0001213900-21-037022.hdr.sgml : 20210715 20210715140944 ACCESSION NUMBER: 0001213900-21-037022 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 46 CONFORMED PERIOD OF REPORT: 20210531 FILED AS OF DATE: 20210715 DATE AS OF CHANGE: 20210715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURA SYSTEMS INC CENTRAL INDEX KEY: 0000826253 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 954106894 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-17249 FILM NUMBER: 211092369 BUSINESS ADDRESS: STREET 1: 10541 ASHDALE STREET CITY: STANTON STATE: CA ZIP: 90680 BUSINESS PHONE: 3106435300 MAIL ADDRESS: STREET 1: 10541 ASHDALE STREET CITY: STANTON STATE: CA ZIP: 90680 10-Q 1 f10q0521_aurasystems.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 31, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

AURA SYSTEMS, INC.

(Exact name of Registrant as specified in its charter)

Delaware		95-4106894
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

20431 North Sea Circle

Lake Forest, CA 92630

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (310) 643-5300

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ☐ NO ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated filer	☒	Smaller Reporting Company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date.

Class		Outstanding July 12, 2021
Common Stock, par value $0.0001 per share		72,988,343 shares

AURA SYSTEMS, INC.

INDEX

Index			Page No.

PART I. FINANCIAL INFORMATION

	ITEM 1.	Financial Statements (Unaudited)	1

		Condensed Balance Sheets as of May 31, 2021 and February 28, 2021	1

		Condensed Statements of Operations for the Three months ended May 31, 2021 and 2020	2

		Condensed Statements of Cash Flows for the Three months ended May 31, 2021 and 2020	3

		Condensed Statements of Changes in Shareholders’ Deficit	4

		Condensed Notes to Financial Statements	5

	ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14

	ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	19

	ITEM 4.	Controls and Procedures	19

PART II. OTHER INFORMATION			20

	ITEM 1.	Legal Proceedings	20

	ITEM 1A.	Risk Factors	20

	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21

	ITEM 3.	Defaults Upon Senior Securities	21

	ITEM 4.	Mine Safety Disclosures	21

	ITEM 5.	Other Information	21

	ITEM 6.	Exhibits	22

	SIGNATURES AND CERTIFICATIONS		23

ITEM 1. FINANCIAL STATEMENTS

AURA SYSTEMS, INC.

CONDENSED BALANCE SHEETS

(Unaudited)

	May 31, 2021			February 28, 2021
Assets
Cash and cash equivalents	$	187,702		$	390,702
Inventory		124,529			94,166
Other current assets		91,751			115,202
Total current assets		403,982			600,070
Fixed Assets, net		30,620			14,870
Right-of-use asset		1,127,670			1,168,053
Deposit		159,595			159,595
Total assets	$	1,721,868		$	1,942,589

Liabilities & Shareholders’ Deficit
Current liabilities
Accounts payable	$	1,892,923		$	1,880,172
Accrued expenses		1,529,273			1,288,107
Customer advances		440,331			440,331
Operating lease liability		160,742			110,587
Notes payable, current portion		100,181			198,331
Notes payable and accrued interest-related party		12,374,486			12,165,015
Total current liabilities		16,497,936			16,082,543
Convertible note payable-related party		3,000,000			3,000,000
Notes payable, non-current		246,360			159,922
Convertible notes payable		1,402,971			1,402,971
Operating lease liability, non-current		1,003,897			1,046,902
Total liabilities		22,151,163			21,692,339

Commitments and contingencies (Note 7)		-			-

Shareholders’ deficit
Common stock: $0.0001 par value; 150,000,000 shares authorized at May 31, 2021 and February 28, 2021; 72,972,775 and 71,107,442 issued and outstanding at May 31, 2021 and February 28, 2021, respectively.		7,297			7,111
Additional paid-in capital		446,555,737			446,126,638
Accumulated deficit		(466,992,329	)		(465,883,499	)
Total shareholders’ deficit		(20,429,295	)		(19,749,750	)
Total liabilities and shareholders’ deficit	$	1,721,868		$	1,942,589

The accompanying notes are an integral part of these unaudited financial statements.

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three-Months Ended
	May 31, 2021			May 31, 2020
Net revenue	$	23,937		$	48,633
Cost of goods sold		49,311			40,393
Gross profit (loss)		(25,374	)		8,240
Operating expenses
Engineering, research & development		80,595			33,994
Selling, general & administration		812,681			343,559
Total operating expenses		893,276			377,553
Loss from operations		(918,650	)		(369,313	)
Other (income) expense:
Interest expense, net		269,575			289,688
Gain on debt settlement		(4,292	)		(46,000	)
Forgiveness of PPP loan		(75,104	)		-
Other income		-			(7,000	)
Loss before tax provision		(1,108,829	)		(606,001	)
Income tax provision		-			-
Net loss	$	(1,108,829	)	$	(606,001	)

Basic and diluted loss per share	$	(0.02	)	$	(0.01	)
Basic and diluted weighted-average shares outstanding		71,932,398			57,072,794

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three-Months Ended
	May 31, 2021			May 31, 2020
Net loss	$	(1,108,829	)	$	(606,001	)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation		772			-
Gain on write-off of liabilities		(4,292	)		-
Forgiveness of PPP loan		(75,104	)		-
Stock-based compensation expense		146,284			77,599
Changes in working capital assets and liabilities:
Inventory		(30,363	)		931
Other current assets		23,452			1,070
Accounts payable and accrued expenses		199,562			55,742
Accrued interest on notes payable		270,274			289,622
Operating lease liability		47,532			-
Cash used in operating activities		(530,713	)		(181,037	)

Cash used in investing activities:
Purchase of property, plant and equipment		(16,522	)		-

Cash flows from financing activities:
Issuance of common stock		283,000			235,000
Payments of notes payable		(30,000	)		(10,000	)
Proceeds from Federal PPP loans		91,235			74,405
Cash provided by financing activities		344,235			299,405

Net increase (decrease) in cash and cash equivalents		(202,999	)		118,368
Beginning cash		390,702			19,807
Ending cash	$	187,702		$	138,174

Cash paid in the period for:
Interest	$	-		$	-
Income taxes	$	-		$	-

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF SHAREHOLDERS’ DEFICIT

(Unaudited)

	Common Stock Shares		Common Stock Amount		Additional Paid-In Capital		Accumulated Deficit			Total Shareholders’ Deficit
Balance, February 29, 2020		56,400,874	$	5,639	$	443,417,452	$	(466,726,027	)	$	(23,302,937	)
Shares issued for cash		1,358,333		135		234,865		-			235,000
Stock-based compensation expense		-		-		77,599		-			77,599
Net loss		-		-		-		(606,001	)		(606,001	)
Balance, May 31, 2020		57,759,207	$	5,774	$	443,729,916	$	(467,332,029	)	$	(23,596,339	)

Balance, February 28, 2021		71,107,442	$	7,111	$	446,126,638	$	(465,883,499	)	$	(19,749,750	)
Shares issued for cash		1,865,333		186		282,815		-			283,001
Stock-based compensation expense		-		-		146,284					146,284
Net loss		-		-		-		(1,108,829	)		(1,108,829	)
Balance, May 31, 2021		72,972,775	$	7,297	$	446,555,737	$	(466,992,328	)	$	(20,429,295	)

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, was founded to engage in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen^®axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets.

Basis of Presentation

In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results.

The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2021 (“Fiscal 2021”) filed with the Securities and Exchange Commission (“SEC”) on June 1, 2021 (“2021 Form 10-K.”).

Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2022; we refer to the current fiscal as Fiscal 2022. The prior fiscal year is Fiscal 2021.

Significant Accounting Policies

For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in our financial statements included in Company’s 2021 Form 10-K.

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Issued Accounting Pronouncements

In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects adoption will have on its financial statements.

In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40), (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU2020-06 amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its financial statements.

NOTE 2 – GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. During the three-month period ended May 31, 2021, the Company reported a net loss of approximately $1.1 million and negative cash flows from operating activities of $0.5 million, respectively. In the event the Company is unable to generate profits and is unable to obtain financing for its working capital requirements, it may have to curtail its business further or cease business altogether. These factors raise substantial doubts about the Company’s ability to continue as a going concern.

Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability.

During the next twelve months we intend to continue to attempt to increase the Company’s operations and focus on the sale of our AuraGen^®®/VIPER products both domestically and internationally and to add to our existing management team. In addition, we plan to complete the move to our new facility for operations, rebuild the engineering and sales teams, and to the extent appropriate, utilize third party contractors to support the operation. We anticipate being able to obtain new sources of funding to support these actions in the upcoming fiscal year.

NOTE 3 – NOTES PAYABLE

Non-related party and related party notes payable principal and accrued interest amounts consisted of the following:

Non-Related Party Promissory Notes (see below)	May 31, 2021			February 28, 2021
Demand promissory notes payable with Mr. Zeitlen as of May 31, 2021 and February 22, 2021, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)	$	10,000		$	10,000
Messrs. Abdou note payable		90,181			120,181
U.S. Payroll Protection Plan loan program		91,235			74,405
U.S. Small Business Administration-Economic Injury Disaster Loan		155,125			153,668
Total Demand and Notes Payable		346,541			358,254

Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.		264,462			264,462
Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.		133,178			133,178
Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.		945,825			945,825
Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.		59,506			59,506
Total Convertible Promissory Notes		1,402,971			1,402,971

Accrued Interest - convertible, demand and notes payable		259,180			239,038
Total Non-Related Party		2,008,692			2,000,263

Notes Payable-Related Party
Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details		3,450,719			3,412,911
Kopple Notes Payable-related party, see Kopple Notes, Note 6:		11,525,192			11,317,787
Mel Gagerman Note Payable, see Gagerman, Note 6:		149,294			147,227
On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.		700,000			700,000
Total Related Party		15,825,204			15,577,925
Total notes payable and accrued interest		17,833,896			17,578,188
Less: Current portion	$	(13,184,565	)	$	(13,015,295	)
Long-term portion	$	4,649,331		$	4,562,893

Demand Promissory Note

Demand promissory note in the amount of $10,000 as of May 31, 2021 and February 28, 2021 is for Mr. Zeitlen, a former director of the Company, issued in September 2015, with an interest rate of 10% per annum.

Abdou and Abdou

On June 20, 2013, the Company entered into an agreement with two individuals, Mr. M. Abdou and Mr. W. Abdou, for the sale of $125,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $24,470 as a discount, which has been fully amortized. There is a remaining balance of $125,000 as of February 28, 2019. In 2016, the Company and the Company’s former Chief Executive Officer, Melvin Gagerman, were named among several other defendants in a lawsuit filed by Messrs. Abdou demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. In January 2017, the Company entered into an agreement with all secured creditors other than Mr. W. Abdou and Mr. M. Abdou. In September 2018, the court entered a judgment of approximately $235,000 plus legal fees of in favor of the Messrs. Abdou. The Company subsequently appealed this judgment and, in September 2019, reached a settlement agreement with these creditors for a principal amount of $325,000, of which approximately $90,000 and $120,000 were outstanding as of May 31 and February 28, 2021, respectively.

Paycheck Protection Plan Loans

During April 2020, the Company ceased operations for approximately 6 weeks in compliance with State of California and the County of Orange public health pronouncements associated with the COVID-19 pandemic. On April 23, 2020, we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company used the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. On April 1, 2021, the company received notification that the principal amount of $74,400 and accrued interest of approximately $700 were forgiven under the terms of the loan program and were recorded as a forgiveness of debt on the Condensed Statements of Operations for the three-months ended May 31, 2021.

On March 3, 2021, the Company received $91,235 pursuant to Paycheck Protection Program Second Draw (“PPP2”) in accordance with legislation approved in December 2020. The terms and conditions of this loan is the same as PPP with the principal amount of $91,325 recognized as part of notes payable, non-current on the balance sheet as of May 31, 2021.

Economic Injury Disaster Loan

Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of May 31 and February 28, 2021, the amounts outstanding, including accrued interest of $5,224 and $3,768, respectively, are $155,125 and $153,668, respectively, and are classified as part of notes payable, non-current on the May 31 and February 28, 2021 balance sheets. On January 6, 2021, the SBA announced a one-year extension of the deferral period for loans that commenced in 2020 delaying payments of principal and interest to July 2022.

Convertible Notes Payable

Kenmont Capital Partners

On May 7 and September 25, 2013, the Company entered into Securities Purchase Agreements for senior convertible notes in the aggregate amount of approximately $1,807,000 (“New Kenmont Notes”) and warrants to Kenmont Capital Partners LP. The New Kenmont Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. On October 31, 2016, the Securities Purchase Agreements were amended and restated to include a provision for mandatory redemption in which 80% of the principal and accrued interest amount of approximately $2,750,000, or approximately $2,200,000, was converted into common shares at a conversion price of $0.75 per share. There was a remaining balance of $549,954 as of May 31 and February 28, 2021, respectively.

LPD Investments

On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“New LPD Note”) and warrants to LPD Investments, Ltd. The New LPD Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $175,793 as a discount, which has been fully amortized. There is a remaining balance of $163,677 as of May 31 and February 28, 2021, respectively.

Guenther

On May 7, 2013, the Company entered into an agreement with an individual, Mr. Guenther, for the sale of $750,000 of secured convertible note payable (the “Note”) and warrants. The Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share and have a 7-year term. The Company recorded $235,985 as a discount, which has been fully amortized. There is a remaining balance of $232,194 as of May 31 and February 28, 2021, respectively.

Dresner and Lempert

On June 20, 2013, the Company entered into an agreement with two individuals, Mr. Dresner and Dr. Lempert, for the sale of $200,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $39,152 as a discount, which has been fully amortized. During Fiscal 2020, Dr. Lempert converted his share of the amount outstanding into common shares and the balance outstanding of $59,506 as of May 31 and February 28, 2021, respectively, is for Dresner exclusively.

Dalrymple – August 2012

On August 10, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $1,000,000 of unsecured Convertible Promissory Note. The Convertible Promissory Note balance together with all accrued interest thereon was due and payable on August 10, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $310,723 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $264,462 as of May 31 and February 28, 2021, respectively.

Dalrymple – October 2012

On October 2, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $500,000 of unsecured Convertible Promissory Note. This Convertible Promissory Note balance together with all accrued interest thereon was due and payable on October 2, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $137,583 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $133,178 as of May 31 and February 28, 2021, respectively.

On January 30, 2017, the Company entered into an agreement entitled First Amendment to Transaction Documents with five of seven secured creditors holding a security interest in all of the Company’s assets except for its patents and other intellectual properties. All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of May 31 and February 28, 2021, respectively, plus any outstanding accrued interest.

NOTE 4 – ACCRUED EXPENSES

Accrued expenses consisted of the following as of the periods referenced below:

	May 31, 2021		February 28, 2021
Accrued payroll and related expenses		640,729		547,412
Accrued interest		259,180		239,038
Accrued interest-related party		450,719		412,911
Other accrued expenses		178,647		88,747
	$	1,529,275	$	1,288,107

Accrued payroll and related expenses consist primarily of salaries and vacation time accrued in prior years but not paid to employees due to our lack of financial resources (see Note 7). Accrued interest consists of amounts due (see Note 3) to holders of convertible promissory notes of $1.4 million and for demand and other promissory notes of approximately $0.3 million at May 31, 2021. The accrued interest-related party is related to principal amount due to Mr. Breslow of $3.0 million as of May 31 and February 28, 2021 (see Note 6).

NOTE 5 – SHAREHOLDERS’ EQUITY

Common Stock

During the three-months ended May 31, 2021, the Company issued approximately 1,865,000 shares of common stock for $283,000 in cash, respectively. During the three-months ended May 31, 2020 the Company issued approximately 1,358,000 shares of common stock for $235,000.

Employee Options and Warrants

The 2011 Director and Executive Officers Stock Option Plan

In October 2011, shareholders approved the 2011 Director and Executive Officers Stock Option Plan at the Company’s annual meeting. Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the three-months ended May 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant.

On February 25, 2021 and during the fourth quarter of Fiscal 2021, the Board approved the grant of 500,000 stock options to our president with an exercise price of $0.50, vesting in equal increments over a twelve-month period and a five-year contractual term. On December 10, 2020 and during the fourth quarter of Fiscal 2021, the Board approved aggregate grants of 1,000,000 stock options to the four other board members with an exercise price of $0.25, vesting in equal increments over a twelve-month period and a five-year contractual term. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date:

	Options Issued During the Three-Months Ended May 31, 2021			Options Issued During the Three-Months Ended February 28, 2021
Exercise Price	$	0.50		$	0.25-$0.50
Share Price	$	0.27		$	0.24-$0.35
Volatility %		226	%		226	%
Risk-Free Rate		0.27	%		0.16%-0.34	%
Expected Term (yrs)		2.80			2.80
Dividend Rate		0	%		0	%

The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $77,599 recorded as part of sales, general and administration expense during the three months ended May 31, 2020.

The aggregate fair value of the 1,500,000 options granted in December 2020 and February 2021 is approximately $382,500, or $0.255 per option, with $146,300 recorded as part of sales, general and administration expense during the three months ended May 31, 2021.

The following tables provide additional information regarding stock options outstanding and exercisable under the 2011 Director and Executive Officers Stock Option Plan for the three-months ended May 31, 2021:

Directors and Officers 2011 plan

	Number of Options		Exercise Price		Weighted Average Intrinsic Value
Outstanding, February 28, 2021		3,790,001	$	0.60	$	225,000
Granted		-		-		-
Exrecised		-		-		-
Cancelled		-		-		-
Outstanding, May 31, 2021		3,790,001	$	0.60	$	225,000

Range of Exercise Price				Stock Options Outstanding				Stock Options Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Options Outstanding				Weighted Average Exercise Price of Optipons Exercisable
$	0.25 to $1.40				3,790,001				2,831,668				3.48			$	0.60			$	0.51

Warrants

Historically, warrants have been issued to investors and others for services and enticements to invest funds with the Company. Generally, these warrants fully vest immediately or within a 90-day period from the date of grant and have an expiration date of five-years from the date of grant. With grants dated prior to Fiscal 2021, an exercise price of $1.40 has been used with all warrants. No warrants were issued in the three-months ended May 31, 2021.

Activity in issued and outstanding warrants is as follows for the three-months ended May 31, 2021:

	Number of Warrants		Exercise Price
Outstanding, February 28, 2021	5,662,272	$	1.40
Granted	-		-
Exrecised	-		-
Cancelled	-		-
Outstanding, May 31, 2021	5,662,272	$	1.40

Other information related to the warrants outstanding and exercisable as of May 31, 2021 follows:

Range of Exercise Price				Stock Warrants Outstanding				Stock Warrants Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Warrants Outstanding				Weighted Average Exercise Price of Warrants Exercisable
$	1.40				5,662,272				5,662,272				1.48			$	1.40			$	1.40

NOTE 6 – RELATED PARTIES TRANSACTIONS

Notes payable-related party, non-current - $3,000,000 on the condensed balance sheets as of May 31 and February 28, 2021 consists of the Breslow Note as described below:

Breslow Note

On January 24, 2017, the Company entered into a Debt Refinancing Agreement with Mr. Breslow, a former Director of the Company. Pursuant to the agreement, both Mr. Breslow and the Company acknowledged that total debt owed to Mr. Breslow was $23,872,614 including $8,890,574 of accrued interest. Mr. Breslow agreed to cancel and forgive all interest due, waive all events of default and sign a new five-year convertible note in the amount of $14,982,041 providing for no interest for six months and interest of 5% per annum thereafter payable monthly in arrears. The note also provides various default provisions. In accordance with the agreement, on February 14, 2018, the effective date of the 1-for-7 reverse stock split, $11,982,041 of the note was converted into 7,403,705 shares of common stock and the then accrued interest of $9,388,338 was forgiven. A new $3,000,000 convertible five-year note representing the remaining balance was entered into at a conversion rate of $1.40. The note bears interest at a rate of 5% per annum payable monthly in arrears with accrued interest of $450,719 and $412,911 recorded as accrued interest-related party (see Note 4) as of May 31 and February 28, 2021, respectively.

Notes payable and accrued interest-related party, current - $12,374,486 on the condensed balance sheet as of May 31, 2021 and $12,165,015 as of February 28, 2021 consists of the Kopple Notes, the Gagerman Note and the Jiangsu Shengfeng Note as set forth below:

Kopple Notes

As of May 31 and February 28, 2021, the principal amount owed to Robert Kopple (former Vice-Chairman of our Board) of $5,607,323 was unchanged. As of May 31, 2021, accrued interest of $5,917,869 was owed to Mr. Kopple for a total balance of $11,525,192. As of February 28, 2021, accrued interest of $5,710,464 was owed to Mr. Kopple for a total balance of $11,317,787.

On August 19, 2013, the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum.

Gagerman Note

On May 31, 2021, the Gagerman note consisted of $82,000 of unsecured note payable plus accrued interest of $67,294 for a total owed to Melvin Gagerman of $149,294, the Company’s former CEO and CFO, pursuant to a demand note entered into on April 5, 2014. Interest accrues at 10% per annum. On February 28, 2021, the amount owed to Gagerman was $147,227.

Jiangsu Shengfeng Note

The Jiangsu Shengfeng non-interest-bearing promissory note of $700,000 was issued in connection with a return of a customer advance. This promissory note, dated November 20, 2019, is with the Company’s Chinese joint venture and consists of a payment plan pursuant to which the $700,000 would be paid over a 12-month period. The principal amount is classified as part of notes payable and accrued interest-related party, current, on the condensed balance sheets as of May 31 and February 28, 2021.

NOTE 7 – COMMITMENTS & CONTINGENCIES

Leases

Prior to Fiscal 2022, our facilities consisted primarily of approximately 20,000 square feet in Stanton, California and a storage facility in Santa Clarita, California. Effective February 28, 2021, we vacated both facilities and consolidated our administrative offices, operations including warehousing within a 17,700 square foot facility in Lake Forest, California under a 66-month rental agreement covering March 1, 2021 through August 31, 2026, with an initial monthly rental rate of approximately $22,000 increasing to a monthly rate of approximately $26,000 in 2026. At February 28, 2021, in accordance with ASC Topic 842, we recognized a right of use (“ROU”) asset and an operating lease liability of approximately $1.2 million, respectively, of which approximately $0.1 million was classified as a current liability and $1.1 million as non-current liability at February 28, 2021. The lease liability is determined by discounting the future lease payments under the lease terms and applying a 10% per annum discount rate to determine the current lease liability. Operating expenses estimated to be approximately $4,000 per month are considered a variable lease component and excluded from the determination of the ROU asset and the lease liability. Other operating expenses, such as utilities and property taxes, are similarly excluded in the calculation of the ROU as they do not represent goods and services provided by the lessor under the terms of the lease. At May 31, 2021, the ROU asset balance was approximately $1,128,000 and the total lease liability was approximately $1,165,000, of which approximately $161,000 was classified as a current liability.

Contingencies

We are subject to the legal proceedings and claims discussed below as well as certain other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and evaluates potential losses on such litigation if the amount of the loss is estimable and the loss is probable. However, the outcome of legal proceedings and claims brought against the Company is subject to significant uncertainty. Although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s expectations, the Company’s financial statements for that reporting period could be materially adversely affected.

In 2017, the Company’s former COO was awarded approximately $238,000 in accrued salary and related charges by the California labor board. The Company believes that this award does not reflect the amount owed which is significantly lower and is exploring all its options and available remedies and is working toward an offer to settle this matter. This amount is part of accrued expenses in the condensed balance sheets as of May 31 and February 28, 2021.

The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.5 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5.9 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director, in connection with these allegations. In 2018, the Court dismissed Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

On March 26, 2019, various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company. On March 27, 2019, those same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as members of the Company’s Board and electing Robert Lempert and David Mann as directors of the Company. These written consents represented a majority of the outstanding shares of the Company’s common stock as of March 26, 2019 and March 27, 2019, respectively. Because of Aura’s refusal to recognize the legal effectiveness of the consents, on April 8, 2019 the stockholders filed suit in the Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming the validity of the consents and declaring that Aura’s Board consists of Ms. Lavut, Mr. Mann, Dr. Lempert, Mr. Douglas and Mr. Diaz-Versón, Jr. On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder plaintiffs, confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a majority of the Company’s outstanding stock acting by written consent (b) Ms. Lavut, Mr. Mann and Dr. Lempert had been validly elected by the holders of a majority of the Company’s outstanding stock acting by written consent, and (c) the Company’s Board of Directors validly consists of Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr. As a result of prior management’s unsuccessful opposition to this stockholders’ action filed in the Court of Chancery, such stockholders may be potentially entitled to recoup their litigation costs from the Company under Delaware’s corporate benefit doctrine and/or other legal provisions. To-date, no final determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Report contains forward-looking statements within the meaning of the federal securities laws. Statements other than statements of historical fact included in this Report, including the statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” regarding future events or prospects are forward-looking statements. The words “approximates,” “believes,” “forecasts,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would,” “could,” “should,” “seek,” “may,” or other similar expressions in this Report, as well as other statements regarding matters that are not historical fact, constitute forward-looking statements. We caution investors that any forward-looking statements presented in this Report are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

●

Our ability to generate positive cash flow from operations;

●

Our ability to obtain additional financing to fund our operations;

●

The impact of economic, political and market conditions on us and our customers;

●

The impact of unfavorable results of legal proceedings;

●

Our exposure to potential liability arising from possible errors and omissions, breach of fiduciary duty, breach of duty of care, waste of corporate assets and/or similar claims that may be asserted against us;

●

Our ability to compete effectively against competitors offering different technologies;

●

Our business development and operating development;

●

Our expectations of growth in demand for our products; and

●

Other risks described under the heading “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q and those risks discussed in our other filings with the Securities and Exchange Commission, including those risks discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended February 28, 2021, issued on June 1, 2021 (as the same may be updated from time to time in subsequent quarterly reports), which discussion is incorporated herein by this reference.

We do not intend to update or revise any forward-looking statements, whether because of new information, future events or otherwise except to the extent required by law. You should interpret all subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf as being expressly qualified by the cautionary statements in this Report. As a result, you should not place undue reliance on these forward-looking statements.

Overview

Our business is based on the exploitation of our Axial Flux Induction solution known as the AuraGen^® for commercial and industrial applications and the VIPER for military applications. Our business model consists of two major components: (i) sales and marketing, (ii) design and engineering. Our sales and marketing approaches are composed of direct sales in North America and the use of agents, distributors. In North America, our primary focus is in (a) mobile exportable power applications, (b) EV applications and (c) U.S. Military applications. The second component of our business model is focused on the design of new products and engineering support for the sales activities described above. The engineering support consists of the introduction of new features for our AuraGen^®/VIPERsolution such as higher power/torque solutions, and different input and output voltages (DC and AC input and output versions)

During Fiscal 2018 and Fiscal 2019, the Company’s engineering, manufacturing, sales, and marketing activities were reduced while we focused on renegotiating numerous financial obligations. During this time, the Company’s agreements with numerous customers, third party vendors, and organizations and entities material to the operation of the Company business were canceled, delayed or terminated. During Fiscal 2018, the Company successfully restructured in excess of $30 million of debt. Robert Kopple, our former Vice Chairman of the Board, was the only significant unsecured note holder that did not executed formal agreements regarding the restructure of his debt. Mr. Kopple claims that he and his affiliates are presently owed approximately $11.5 million. We dispute Mr. Kopple’s claims. See “Item 3. Legal Proceedings” included in our Annual Report on Form 10-K for Fiscal 2021 and Part II, Other Information, contained in this Quarterly Report for information regarding the dispute with Mr. Kopple regarding these transactions. As of the filing of this Quarterly Report, Mr. Kopple has not accepted our numerous offers to settle this debt and continues to demand that as part of any such resolution, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion n of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

In Fiscal 2019, we effectuated a one-for-seven reverse stock split and began increasing our engineering and manufacturing activities.

In Fiscal 2020 stockholders of the Company successfully removed Ronald Buschur, William Anderson and Si Ryong Yu from the Company’s Board of Directors and elected Ms. Cipora Lavut, Mr. David Mann and Dr. Robert Lempert as directors of the Company in their stead. See Item 3, Legal Proceedings for more information. Also, in Fiscal 2020, Melvin Gagerman –– Aura’s CEO and CFO since 2006 –– was replaced. In July 2019 Ms. Lavut succeeded Mr. Gagerman as President and Mr. Mann succeeded Mr. Gagerman as CFO. Dr. Lempert was appointed as Secretary of the Company by the Board of Directors also in July 2019. In the second half of Fiscal 2020, the Company began significantly increasing its engineering, manufacturing and marketing activities. From July 8, 2019 through the end of Fiscal year 2021 (February 28, 2021), we shipped more than 140 units to customers (more than a ten-fold increase over Fiscal 2019). Although our operations were impacted in Fiscal 2021 by the COVID-19 pandemic, during Fiscal 2021 we continued to expand our engineering and manufacturing capabilities. Our engineering, research and development costs for the three months ended May 31, 2020 was approximately $34,000 as compared to $81,000 for the same period of Fiscal 2022. Subsequent to the end of Fiscal 2021, we relocated all administrative offices and operations to a new state-of-the-art facility consisting of approximately 18,000 square feet in Lake Forest, California. This new facility is wholly occupied by Aura.

Critical Accounting Policies and Estimates

Our management’s discussion and analysis of our financial conditions and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. In preparing our financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. The full impact of the COVID-19 pandemic is unknown and cannot be reasonably estimated for these key estimates and assumptions. However, we made appropriate accounting estimates based on the facts and circumstances available as of the reporting date. To the extent that there are differences between these estimates and actual results, our financial statements may be materially affected.

Revenue Recognition

The core principle of ASC 606, Revenue from Contracts with Customers (“ASC 606”), is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In applying ASC 606, all revenue transactions must be evaluated using a five-step approach to determine the amount and timing of revenue to be recognized. The five-step approach requires (1) identifying the contract with the customer, (2) identifying the performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations in the contract and (5) recognizing revenue when performance obligations are satisfied.

Our primary source of revenue is the manufacture and delivery of AuraGen/VIPER sets used primarily in mobile power applications, which represented 100% of our revenues of approximately $24,000 and $49,000 for the three-months ended May 31, 2021 and 2020, respectively.

In accordance with ASC 606, we recognize the entirety of the revenue, net of discounts, for our AuraGen/VIPER sets at time of product delivery to the customer (i.e., point-in-time sale), which also corresponds to the passage of legal title to the customer and the satisfaction of our single performance obligation to the customer. Our payment terms are cash payment due upon delivery and typically includes a 2.5% price discount in accordance with this policy. Our commercial terms and conditions do not include a right of return for reasons other than a defect in performance or quality. We offer 18 months assurance-type warranty covering material and manufacturing defects, which we account for under the guidance of ASC 460, Guarantees. We have a limited history of shipments, and, as such, we have not recorded a warranty liability on our balance sheets as of May 31 and February 28, 2021, respectively; however, we expect warranty claims to eventually be nil, therefore, we have not delayed the recognition of revenue during Fiscal 2022 and 2021.

Stock-Based Compensation

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation – Stock Compensation”, which requires the measurement of all share-based payments to employees, including grants of employee stock options, using a fair value-based method and the recording of such expense in the statements of operations.

We account for stock option and warrant grants issued and vesting to non-employees, such as consultants and third parties, in accordance with FASB ASC 718, “Compensation – Stock Compensation”, where appropriate, whereas the fair value of the equity-based compensation is based upon the measurement date as determined at the earlier of either (a) the date at which a performance commitment is reached or (b) at the date at which the necessary performance to earn the equity instruments is complete.

In accordance with established public company accounting practice, we have consistently utilized the Black-Scholes option-pricing model to calculate the fair value of stock options and warrants issued as compensation, primarily to management, employees, and directors. The Black-Scholes option-pricing model is a widely accepted method of valuation that public companies typically utilize to calculate the fair value of options and warrants that they issue in such circumstances. During the three-month period ended May 31, 2020, our Board of Directors awarded a total of 1,250,000 stock options to the five members of the board, which resulted in an aggregate fair value of $193,500 of which $77,600 was recorded as stock-based compensation in the three-months ended May 31, 2020. During the three months ended February 28, 2021, the board approved an aggregate grant of 1,500,000 stock options to board members, which resulted in an aggregate fair value of $382,500, of which $146,300 was recorded as stock-based compensation cost in the three-months ended May 31, 2021.

Operating Leases

We adopted ASC 842, Leases, in Fiscal 2020, which required that public companies evaluate all operating leases in accordance with ASC 842 and recognize a lease liability on the balance sheet by determining the present value of the remaining lease payments for each lease using a discount rate based on the Company’s incremental borrowing rate. A corresponding right-of-use asset is also recognized that is amortized over the remaining term of the lease. Throughout Fiscal 2020 and the majority of Fiscal 2021, we did not implement the new guidance to our existing leases because the guidance does not require application of the standard for leases that are less than 12 months with lease renewal unlikely. All of the facility leases were month-to-month with management’s intention of exiting the leases and facilities as soon as practical. In February 2021, we entered into a 66-month facility lease in Lake Forest, CA that began on March 1, 2021, which resulted in the application of ASC 842 for the fiscal year ended February 28, 2021. As of February 28, 2020, we recognized a lease liability and a right-of-use asset of $1.2 million, respectively. During Fiscal 2022 and beyond, we will be applying the new lease standard to this lease and any other operating leases we enter into in the future.

Impact of COVID-19

The COVID-19 global pandemic has negatively affected the global economy, disrupted global supply chains, and created extreme volatility and disruptions to capital and credit markets in the global financial markets. We began to see the impact of COVID-19 during our fourth quarter of Fiscal 2020 with our Chinese joint venture’s manufacturing facilities being required to close and many of our customers suspending their own operations due to the COVID-19 pandemic. As a result, net sales and production levels during the fourth quarter of Fiscal 2020, the entirety of Fiscal 2021 and the first quarter of Fiscal 2022 were significantly reduced, thus impacting our results of operations during these quarters.

In response to the COVID-19 pandemic and business disruption, we implemented certain measures to manage costs, preserve liquidity and enhance employee safety. These measures included the following:

●

Reduction of payroll related expenses including temporary furloughs during the first quarter of Fiscal 2021.

●

Deferral of capital expenditures and other discretionary expenditures

●

Safety programs including disinfecting activities in our facilities

The extent of the impact of the COVID-19 pandemic on our business, financial results and liquidity will depend largely on current and future developments, including the containment of COVID-19 within the U.S. and globally, the timing and effectiveness of vaccine rollout, the possible spread of Covid-19 variants and the impact on capital and financial markets and the related impact on our customers, especially in the commercial vehicle markets. These future developments are outside of our control, are highly uncertain and cannot be predicted. If the impact is prolonged, then it can further increase the difficulty of planning for operations and may require us to take further actions as it relates to costs and liquidity. These and other potential impacts of the COVID-19 pandemic have adversely impacted our results for the entirety of Fiscal 2021, the first quarter of fiscal year 2022, and could be impactful for the balance of Fiscal 2022.

Going Concern

Results of Operations

Three months ended May 31, 2021 compared to three months ended May 31, 2020

Net revenue was approximately $23,900 for the three-months ended May 31, 2021 (the “Three-Months FY2022”) compared to approximately $49,000 for the three-months ended May 31, 2020 (the “Three-Months FY2020”). During the current quarter of 2022, we delivered 3 generator unit as compared to 8 units delivered in the same quarter in the prior year. Revenue year-on-year has been negatively impacted by the COVID-19 pandemic. We cannot project with confidence the timing or amount of revenue that we can expect until the pandemic is under control globally including a successful rollout of the vaccine programs now underway.

Cost of goods sold was approximately $49,300 in the Three-Months FY2022 compared to approximately $40,400 in the Three-Months FY2021 resulting in a gross loss of $25,400, or a gross margin loss of 106%, and a $8,200 gross profit in the Three-Months FY2021 and a gross margin of 17%, respectively. The gross loss and related gross margin loss for the Three-Months FY2022 were largely influenced by the low volume of shipments in the quarter which reduced our ability to fully absorb fixed operating costs including higher operating costs related to the new facility. The gross margin of 17% in the Three-Months FY2021 was also influenced by the reduced demand for generator sets caused by the onset of Covid-19.

Engineering, research and development expenses were approximately $81,000 in the Three-Months FY2022, compared to approximately $34,000 in the Three-Months FY2021, or an increase of 138%. The higher costs are in relation to the development of a new electronic control unit (“ECU”).

Selling, general and administration (“SG&A”) expense increased by approximately $469,100 (137%) to approximately $812,700 in the Three-Months FY2022 from approximately $343,600 in the Three-Months FY2021. During Three-Months FY2022, we recorded increased expense for (i) $146,300 of stock-based compensation expense related to the recent grant of 1,500,000 options to members of the board of directors, (ii) $34,000 in one-time costs to physically consolidate our operations in Lake Forest, CA (iii) higher recurring facilities rent costs of $51,000 due to move to new facility, (iii) higher legal costs of $101,000 due to ongoing litigation costs (iv) $31,500 in higher accounting fees due to completion of the Fiscal 2021 annual audit in the first quarter of this fiscal year as compared to the second quarter of Fiscal 2021 for the prior year’s annual audit, (v) write-off of $61,000 for deferred sales compensation costs determined not to be recoverable, (vi) additional salary expense for three advisors of $92,600, and (vii) all other expense increases of approximately $29,000, partially offset by a reduction of $77,600 in stock-based compensation costs related to 1,250,000 options granted in March 2020 fully amortized by February 28, 2021.

Interest expense in the Three-Months FY2022 decreased approximately $20,000 or 7%, to approximately $270,000 from approximately $290,000 in the Three-Months FY2021 due to the reduction of interest-bearing principal amounts outstanding of approximately $700,000 over the prior twelve-month period.

Other income in the Three-Months FY2022 was approximately $4,000, as compared to $53,000 in the same period of Fiscal 2021 consisting of a legal matter settlement occurring last year of $46,000 and a $7,000 one-time benefit related to the procurement of the initial PPP loan for $74,400 in April 2020. In the Three-Months FY2022 period, we recorded a gain of approximately $75,000 in connection with the forgiveness of the principal and accrued interest related to the initial PPP loan.

Net loss for the Three-Months FY2022 increased by approximately $503,000, to a loss of $1,109,000 from a loss of $606,000 in the Three-Months FY2021 attributed to (i) increased operating loss of $549,000 and (ii) reduced other income of $49,000 partially offset by (i) less interest expense of $20,000 and (ii) a $75,000 gain on forgiveness of debt.

Liquidity and Capital Resources

Net cash used in operations for the three-months ended May 31, 2021, was approximately $531,000, an increase of $350,000 from the comparable period in the prior fiscal year. Net cash provided by financing activities during the three-months ended May 31, 2021, was approximately $344,000 consisting of (i) cash proceeds from issuance of common stock of $283,000, (ii) proceeds of $91,000 related to the U.S. federal Paycheck Protection Program Second Draw (“PPP2”) loan program related to COVID-19, partially offset by $30,000 principal payments on a note payable. The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs.

There was acquisition of property and equipment in the amount of $17,000 during the three-months ended May 31, 2021. There was no acquisition of property and equipment during the corresponding period of Fiscal 2021.

The total of accrued expenses as of May 31, 2021 increased by approximately $0.2 million to $1.5 million from approximately $1.3 million as of February 28, 2021 due to (i) accrued interest of $58,000 (ii) increase of accrued payroll of $93,000 and (iii) higher accrued professional fees of $90,000.

The Company had a deficit of $20.4 million in shareholders’ equity as of May 31, 2021, compared to $19.7 million as of February 28, 2021 with the net negative change of $0.7 million attributed to (i) net loss year-to-date of approximately $1.1 million (ii) the net issuance of approximately 1.9 million shares valued at approximately $0.3 million for cash and (iii) approximately $0.1 million was recognized as expense during the three-months ended May 31, 2021.

On April 23, 2020, we obtained a PPP loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, loan payments are deferred for 10 months following the last day of the covered period or June 23, 2020, balance is payable in 24 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company used the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. On April 1, 2021, we received notification that our application for loan forgiveness was accepted and approximately $75,100 of accrued interest and principal was forgiven.

On July 1, 2020, we obtained an EIDL loan in the amount of $149,900 administered by the SBA. As required under this program, the proceeds of the loan are to be used for payments of ordinary working capital needs negatively impacted by the COVID-19 pandemic. Interest accrues from the date of the loan of July 1, 2020 at a rate of 3.75% per annum, a loan term of 30 years, no prepayment penalties or fees, and there is a one-year deferral period during which interest accrues but no payments are required to be made. Following the deferral period for a period of 29 years, an estimated monthly payment of $734 is required to fully amortize the principal and accrued interest over the term of the loan. The Company pledged the assets of the Company as collateral for the loan. In January 2021, the SBA announced that the deferral period was being extended for another one-year period to July 2022. No other terms were adjusted; the monthly payment would become $778 per month over the remaining term.

On March 3, 2021, we received proceeds of $91,235 from a Second Draw PPP loan (“PPP2”) with the same terms and conditions that were applicable to the April 2020 PPP loan.

In the past, in order to generate liquidity, we have relied upon external sources of financing, principally equity financing and private indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. The issuance of additional shares of equity in connection with any such financing could dilute the interests of our existing stockholders, and such dilution could be substantial. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to provide disclosure under this Item 3.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the specified time periods. For the last 3 Fiscal years, these control and procedures broke down due to insufficient capital to maintain such controls and procedures. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to its management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period covered by this report, the Company’s management evaluated, with the participation of the Company’s Principal Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures. Based on the evaluation, the Company’s Principal Executive Officer and Chief Financial Officer concluded that these controls and procedures were effective as of the end of the period covered by this report in ensuring that information requiring disclosure is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. The Company continues to remediate the findings contained in our Annual Report on Form 10-K, for the Fiscal year ended February 28, 2021, issued on June 1, 2021.

Changes in Internal Control over Financial Reporting

There have been no other changes in our internal control over financial reporting during our fiscal quarter ended May 31, 2021, not previously identified in our Annual Report on Form 10-K, for the Fiscal year ended February 28, 2021 and issued on June 1, 2021 which have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. Legal Proceedings

The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.5 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5.9 million Mr. Kopple claims to be owed for interest, loan fees and late payment feess) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director in connection with these allegations. In 2018, the Court sustained demurrers by Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman, and as a result of these successful demurrers, all four of these defendants have been dismissed from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

ITEM 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A, “Risk Factors,” of the Company’s Fiscal 2021 Annual Report on Form 10-K issued on June 1, 2021.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the three-months ended May 31, 2021, we issued 1,865,333 shares of common stock for cash proceeds of $283,000.

ITEM 3. Defaults Upon Senior Securities.

As of the date of this filing, Robert Kopple, our former Vice Chairman of the Board, is the only significant unsecured note holder that has not executed formal agreements regarding the restructure of his debt. Mr. Kopple claims that he and his affiliates are owed approximately $11.5 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5.9 million Mr. Kopple claims to be owed for interest, loan fees and late payment fees) on terms significantly preferable to other similarly situated unsecured creditors as well as warrants to purchase approximately 3.3 million shares of our common stock. We dispute Mr. Kopple’s claims and we are currently in a legal dispute regarding these claims. See “Item 1. Legal Proceedings” included elsewhere in this Quarterly Report on Form 10-Q for information regarding the dispute with Mr. Kopple regarding these transactions as well as “Note 3 – Notes Payable” and “Note 6 – Related Parties Transactions” to the Company’s condensed financial statements, “Liquidity and Capital Resources” in “Item 2 and Management’s Discussion and Analysis of Financial Condition and Results of Operations” elsewhere in this quarterly report on Form 10-Q for additional information regarding amounts that may be owed under the Company’s notes payable and the recent restructuring of certain Company debt. Mr. Kopple has not accepted our numerous offers to settle this debt and continues to demand that as part of any such resolution, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

In June 2014, we entered into a Financing Letter of Agreement (the “June 2014 Agreement”) with two affiliate entities of Mr. Kopple, KF Business Ventures and the Kopple Family Partnership (the “Additional Kopple Parties”), pursuant to which the Additional Kopple Parties loaned us an additional $1,000,000 (the “June 2014 Loan”). In connection with the June 2014 Loan, Mr. Kopple also added $202,205 in penalties and accrued interest, credited us with $200,000 for amounts previously repaid by us and several earlier advances into a single new note (the “June 2014 Kopple Note”) in the principal amount of $2,715,2067 and bearing simple interest at a rate of 10% per annum.

Pursuant to the June 2014 Agreement, the Kopple Parties also placed various restrictions on our ability to raise additional capital, hire qualified personnel and pay certain expenses without his prior approval for so long as the principal amount of his note remained outstanding. The June 2014 Kopple Note also required us to issue Mr. Kopple a stock purchase warrant (the “June 2014 Kopple Warrant”) to purchase approximately 771,000 shares of our common stock at an exercise price of $0.70 per share, to be exercisable for seven years. Additionally, if we borrowed funds, issued capital stock or rights to acquire or convert into capital stock, or granted rights in respect to territories to any person for cash consideration of more than $5 million in the aggregate after the date of the June 2014 Kopple Note, we would be required to pay the entire amount of such cash consideration in excess of $5 million as a mandatory prepayment of the June 2014 Kopple Note. Additionally, Mr. Kopple required a default provision providing that in the event that the entire outstanding balance of the June 2014 Kopple Note was not paid in full prior to October 1, 2014, then for each consecutive calendar month during the period beginning October 1, 2014 and ending March 31, 2015, we would issue to Mr. Kopple additional stock purchase warrants, each to purchase 416,458 shares of our common stock, up to a maximum aggregate of approximately 2.5 million shares of our common stock, at $0.70 per share (the “Kopple Penalty Warrants”), the Kopple Penalty Warranties to be exercisable for seven years from the time of their respective issuances. In addition to the Kopple Penalty Warrants, the default provision under the June 2014 Kopple Note provides for a 5% late charge on the total amount due plus 15% per year interest. We have not repaid the Kopple Parties in full for the amounts loaned to us. Additionally, we have not issued any of the Kopple Penalty Warrants and management believes that Mr. Kopple is not entitled to receive them. We have also cancelled the June 2014 Kopple Warrant.

We consider the transactions described above with Mr. Kopple to be related party transactions.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information.

None.

ITEM 6. Exhibits

31.1		Certification pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

31.2		Certification pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

32.1		Certification of Principal Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. § 1350, as Adopted Pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Schema Document

101.CAL		XBRL Calculation Linkbase Document

101.DEF		XBRL Definition Linkbase

101.LAB		XBRL Label Linkbase Document

101.PRE		XBRL Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: July 15, 2021	AURA SYSTEMS, INC.
	(Registrant)

	By:	/s/ Cipora Lavut
		Cipora Lavut
		President

EX-31.1 2 f10q0521ex31-1_aurasystems.htm CERTIFICATION

Exhibit 31.1

CERTIFICATION

I, Cipora Lavut, certify that:

I have reviewed the first quarterly report of Aura Systems Inc for fiscal year 2022.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: July 15, 2021
	By:	/s/ Cipora Lavut
		Cipora Lavut
		President

EX-31.2 3 f10q0521ex31-2_aurasystems.htm CERTIFICATION

Exhibit 31.2

CERTIFICATION

I, David Mann, certify that:

I have reviewed the first quarterly report of Aura Systems Inc for fiscal year 2022.

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: July 15, 2021
	By:	/s/ David Mann
		David Mann
		Chief Financial Officer

EX-32.1 4 f10q0521ex32-1_aurasystems.htm CERTIFICATION

Exhibit 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Cipora Lavut, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Aura Systems, Inc. on Form 10-Q for the period ended May 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Aura Systems, Inc. at the dates and for the periods indicated.

Date: July 15, 2021
	By:	/s/ Cipora Lavut
		Cipora Lavut
		President

I, David Mann, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Aura Systems, Inc. on Form 10-Q for the period ended May 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Aura Systems, Inc. at the dates and for the periods indicated.

Date: July 15, 2021
	By:	/s/ David Mann
		David Mann
		Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Aura Systems, Inc. and will be retained by Aura Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 ausi-20210531.xml XBRL INSTANCE FILE 0000826253 2021-03-01 2021-05-31 0000826253 2021-07-12 0000826253 2021-05-31 0000826253 2021-02-28 0000826253 2020-03-01 2020-05-31 0000826253 2020-02-29 0000826253 2020-05-31 0000826253 us-gaap:CommonStockMember 2020-02-29 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0000826253 us-gaap:RetainedEarningsMember 2020-02-29 0000826253 us-gaap:CommonStockMember 2020-03-01 2020-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-03-01 2020-05-31 0000826253 us-gaap:RetainedEarningsMember 2020-03-01 2020-05-31 0000826253 us-gaap:CommonStockMember 2020-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0000826253 us-gaap:RetainedEarningsMember 2020-05-31 0000826253 us-gaap:CommonStockMember 2021-02-28 0000826253 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0000826253 us-gaap:RetainedEarningsMember 2021-02-28 0000826253 us-gaap:CommonStockMember 2021-03-01 2021-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-05-31 0000826253 us-gaap:RetainedEarningsMember 2021-03-01 2021-05-31 0000826253 us-gaap:CommonStockMember 2021-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0000826253 us-gaap:RetainedEarningsMember 2021-05-31 0000826253 ausi:DemandPromissoryNotesPayableMember 2021-05-31 0000826253 ausi:DemandPromissoryNotesPayableMember 2021-02-28 0000826253 ausi:DemandPromissoryNotesPayableMember 2015-09-30 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2013-06-01 2013-06-20 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2013-06-20 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2018-03-01 2019-02-28 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2018-09-01 2018-09-30 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-05-31 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2021-02-28 0000826253 2020-04-01 2020-04-23 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2013-09-25 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2021-05-31 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2016-10-01 2016-10-31 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-05-31 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2021-02-28 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2021-05-31 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-05-31 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2021-02-28 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-05-31 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2021-02-28 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2013-06-01 2013-06-20 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2013-06-20 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-05-31 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2021-02-01 2021-02-28 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2012-08-01 2012-08-10 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2017-08-10 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleDebtMember 2017-08-01 2017-08-10 0000826253 ausi:DalrympleMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2018-01-11 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-05-31 0000826253 ausi:DalrympleMember us-gaap:ConvertibleNotesPayableMember us-gaap:UnsecuredDebtMember 2020-03-01 2021-02-28 0000826253 ausi:DalrympleMember us-gaap:ConvertibleNotesPayableMember us-gaap:UnsecuredDebtMember 2021-10-01 2021-10-02 0000826253 ausi:DalrympleMember us-gaap:ConvertibleNotesPayableMember us-gaap:UnsecuredDebtMember 2021-10-02 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2018-01-11 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2018-01-01 2018-01-11 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2021-02-28 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleDebtMember 2017-01-01 2017-01-30 0000826253 ausi:MessrsAbdouNotesPayableMember 2021-05-31 0000826253 ausi:MessrsAbdouNotesPayableMember 2021-02-28 0000826253 ausi:USPayrollProtectionPlanLoanProgramMember 2021-05-31 0000826253 ausi:USPayrollProtectionPlanLoanProgramMember 2021-02-28 0000826253 ausi:USSmallBusinessAdministrationEconomicInjuryDisasterLoanMember 2021-05-31 0000826253 ausi:USSmallBusinessAdministrationEconomicInjuryDisasterLoanMember 2021-02-28 0000826253 ausi:ConvertibleMember 2021-05-31 0000826253 ausi:ConvertibleMember 2021-02-28 0000826253 ausi:ConvertibleMember 2021-03-01 2021-05-31 0000826253 ausi:ConvertibleOneMember 2021-05-31 0000826253 ausi:ConvertibleOneMember 2021-02-28 0000826253 ausi:ConvertibleOneMember 2021-03-01 2021-05-31 0000826253 ausi:ConvertibleTwoMember 2021-05-31 0000826253 ausi:ConvertibleTwoMember 2021-02-28 0000826253 ausi:ConvertibleTwoMember 2021-03-01 2021-05-31 0000826253 ausi:ConvertibleThreeMember 2021-05-31 0000826253 ausi:ConvertibleThreeMember 2021-02-28 0000826253 ausi:ConvertibleThreeMember 2021-03-01 2021-05-31 0000826253 ausi:NotesPayableMember 2021-05-31 0000826253 ausi:NotesPayableMember 2021-02-28 0000826253 ausi:KoppleNotesPayableRelatedPartyMember 2021-05-31 0000826253 ausi:KoppleNotesPayableRelatedPartyMember 2021-02-28 0000826253 ausi:MelGagermanNotesPayableMember 2021-05-31 0000826253 ausi:MelGagermanNotesPayableMember 2021-02-28 0000826253 ausi:JiangsuShengfengMember 2021-05-31 0000826253 ausi:JiangsuShengfengMember 2021-02-28 0000826253 2020-12-01 2021-02-28 0000826253 2011-10-01 0000826253 2019-03-19 0000826253 2021-02-01 2021-02-25 0000826253 2021-02-25 0000826253 2020-12-01 2020-12-10 0000826253 2020-12-10 0000826253 2020-01-01 2020-03-31 0000826253 2020-12-01 2020-12-31 0000826253 2020-03-01 2021-02-28 0000826253 ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2021-03-01 2021-05-31 0000826253 ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2021-05-31 0000826253 srt:MinimumMember ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2021-02-28 0000826253 srt:MaximumMember ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2021-02-28 0000826253 ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2020-12-01 2021-02-28 0000826253 srt:MinimumMember ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2020-12-01 2021-02-28 0000826253 srt:MaximumMember ausi:TwoThousandElevenDirectorAndExecutiveOfficersStockOptionPlanMember 2020-12-01 2021-02-28 0000826253 ausi:DirectorsAndOfficers2011PlanMember 2021-05-31 0000826253 ausi:DirectorsAndOfficers2011PlanMember 2021-03-01 2021-05-31 0000826253 srt:MinimumMember ausi:DirectorsAndOfficers2011PlanMember 2021-05-31 0000826253 srt:MaximumMember ausi:DirectorsAndOfficers2011PlanMember 2021-05-31 0000826253 srt:DirectorMember 2017-01-24 0000826253 srt:DirectorMember us-gaap:ConvertibleDebtMember 2017-01-01 2017-01-24 0000826253 srt:DirectorMember 2018-02-01 2018-02-14 0000826253 us-gaap:CommonStockMember 2018-02-01 2018-02-14 0000826253 srt:DirectorMember 2018-02-14 0000826253 srt:DirectorMember 2021-05-01 2021-05-31 0000826253 srt:DirectorMember 2020-03-01 2021-02-28 0000826253 srt:BoardOfDirectorsChairmanMember 2021-05-31 0000826253 srt:BoardOfDirectorsChairmanMember 2021-05-01 2021-05-31 0000826253 srt:BoardOfDirectorsChairmanMember 2021-02-01 2021-02-28 0000826253 srt:BoardOfDirectorsChairmanMember 2021-02-28 0000826253 srt:BoardOfDirectorsChairmanMember 2013-08-01 2013-08-19 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2021-05-31 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2021-05-01 2021-05-31 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2021-02-01 2021-02-28 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2021-02-28 0000826253 ausi:JiangsuShengfengMember 2019-11-01 2019-11-20 0000826253 ausi:JiangsuShengfengMember 2019-11-20 0000826253 ausi:RightOfUseAssetsMember 2021-02-28 0000826253 ausi:RightOfUseAssetsMember 2020-03-01 2021-02-28 0000826253 ausi:CaliforniaLaborBoardMember 2021-05-31 0000826253 srt:DirectorMember 2019-03-01 2019-03-26 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:sqm false --02-28 Q1 2022 2021-05-31 10-Q 0000826253 Yes false 0-17249 Non-accelerated Filer DE No AURA SYSTEMS INC false true 72988343

187702

390702

124529

94166

91751

115202

403982

600070

30620

14870

1127670

1168053

159595

1721868

1942589

1892923

1880172

1529273

1288107

440331

160742

110587

100181

198331

12374486

12165015

16497936

16082543

3000000

246360

159922

1402971 1402971

1003897

1046902

22151163

21692339

7297

7111

0.0001

150000000

72972775

71107442

72972775

71107442

446555737

446126638

-466992329

-465883499

-20429295

-19749750

1721868

1942589

23937

48633

49311

40393

-25374

8240

80595

33994

812681

343559

893276

377553

-918650

-369313

269575

289688

4292 46000 -75104

7000

-1108829

-606001

-1108829

-606001

-0.02

-0.01

71932398

57072794

772

4292 75104

146284

77599

30363

-931

-23452

-1070

199562

55742

270274

289622

-47532

-530713

-181037

16522

283000

235000

30000

10000

91235 74405

344235

299405

-202999

118368

390702

19807

187702

138174

56400874

5639

443417452

-466726027

-23302937

1358333

135

234865

235000

77599 77599

-606001

57759207

5774

443729916

-467332029

-23596339

71107442

7111

446126638

-465883499

1865333

186

282815

283001

146284 146284

-1108829

72972775

7297

446555737

-466992328

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, was founded to engage in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen® axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets. Basis of Presentation In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results. The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2021 (“Fiscal 2021”) filed with the Securities and Exchange Commission (“SEC”) on June 1, 2021 (“2021 Form 10-K.”). Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2022; we refer to the current fiscal as Fiscal 2022. The prior fiscal year is Fiscal 2021. Significant Accounting Policies For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in our financial statements included in Company’s 2021 Form 10-K. Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Recently Issued Accounting Pronouncements In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects adoption will have on its financial statements. In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40), (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU2020-06 amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its financial statements.

1100000

500000

NOTE 3 – NOTES PAYABLE Non-related party and related party notes payable principal and accrued interest amounts consisted of the following: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Non-Related Party Promissory Notes (see below)</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">May 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">February 28, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Demand promissory notes payable with Mr. Zeitlen as of May 31, 2021 and February 22, 2021, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Messrs. Abdou note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90,181</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">120,181</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">U.S. Payroll Protection Plan loan program</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,405</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">U.S. Small Business Administration-Economic Injury Disaster Loan</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,125</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">153,668</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left">Total Demand and Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">346,541</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">358,254</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,462</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,462</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133,178</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133,178</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">945,825</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">945,825</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">59,506</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">59,506</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Convertible Promissory Notes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,402,971</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,402,971</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued Interest - convertible, demand and notes payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">259,180</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">239,038</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-Related Party</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,008,692</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,263</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Notes Payable-Related Party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,450,719</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,412,911</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Kopple Notes Payable-related party, see Kopple Notes, Note 6:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,525,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,317,787</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Mel Gagerman Note Payable, see Gagerman, Note 6:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,294</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">147,227</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">700,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">700,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Related Party</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,825,204</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,577,925</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total notes payable and accrued interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,833,896</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,578,188</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,184,565</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,015,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 4pt">Long-term portion</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,649,331</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,562,893</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> Demand Promissory Note Demand promissory note in the amount of $10,000 as of May 31, 2021 and February 28, 2021 is for Mr. Zeitlen, a former director of the Company, issued in September 2015, with an interest rate of 10% per annum. Abdou and Abdou On June 20, 2013, the Company entered into an agreement with two individuals, Mr. M. Abdou and Mr. W. Abdou, for the sale of $125,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $24,470 as a discount, which has been fully amortized. There is a remaining balance of $125,000 as of February 28, 2019. In 2016, the Company and the Company’s former Chief Executive Officer, Melvin Gagerman, were named among several other defendants in a lawsuit filed by Messrs. Abdou demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. In January 2017, the Company entered into an agreement with all secured creditors other than Mr. W. Abdou and Mr. M. Abdou. In September 2018, the court entered a judgment of approximately $235,000 plus legal fees of in favor of the Messrs. Abdou. The Company subsequently appealed this judgment and, in September 2019, reached a settlement agreement with these creditors for a principal amount of $325,000, of which approximately $90,000 and $120,000 were outstanding as of May 31 and February 28, 2021, respectively. Paycheck Protection Plan Loans During April 2020, the Company ceased operations for approximately 6 weeks in compliance with State of California and the County of Orange public health pronouncements associated with the COVID-19 pandemic. On April 23, 2020, we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company used the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. On April 1, 2021, the company received notification that the principal amount of $74,400 and accrued interest of approximately $700 were forgiven under the terms of the loan program and were recorded as a forgiveness of debt on the Condensed Statements of Operations for the three-months ended May 31, 2021. On March 3, 2021, the Company received $91,235 pursuant to Paycheck Protection Program Second Draw (“PPP2”) in accordance with legislation approved in December 2020. The terms and conditions of this loan is the same as PPP with the principal amount of $91,325 recognized as part of notes payable, non-current on the balance sheet as of May 31, 2021. Economic Injury Disaster Loan Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of May 31 and February 28, 2021, the amounts outstanding, including accrued interest of $5,224 and $3,768, respectively, are $155,125 and $153,668, respectively, and are classified as part of notes payable, non-current on the May 31 and February 28, 2021 balance sheets. On January 6, 2021, the SBA announced a one-year extension of the deferral period for loans that commenced in 2020 delaying payments of principal and interest to July 2022. Convertible Notes Payable Kenmont Capital Partners On May 7 and September 25, 2013, the Company entered into Securities Purchase Agreements for senior convertible notes in the aggregate amount of approximately $1,807,000 (“New Kenmont Notes”) and warrants to Kenmont Capital Partners LP. The New Kenmont Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. On October 31, 2016, the Securities Purchase Agreements were amended and restated to include a provision for mandatory redemption in which 80% of the principal and accrued interest amount of approximately $2,750,000, or approximately $2,200,000, was converted into common shares at a conversion price of $0.75 per share. There was a remaining balance of $549,954 as of May 31 and February 28, 2021, respectively. LPD Investments On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“New LPD Note”) and warrants to LPD Investments, Ltd. The New LPD Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $175,793 as a discount, which has been fully amortized. There is a remaining balance of $163,677 as of May 31 and February 28, 2021, respectively. Guenther On May 7, 2013, the Company entered into an agreement with an individual, Mr. Guenther, for the sale of $750,000 of secured convertible note payable (the “Note”) and warrants. The Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share and have a 7-year term. The Company recorded $235,985 as a discount, which has been fully amortized. There is a remaining balance of $232,194 as of May 31 and February 28, 2021, respectively. Dresner and Lempert On June 20, 2013, the Company entered into an agreement with two individuals, Mr. Dresner and Dr. Lempert, for the sale of $200,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $39,152 as a discount, which has been fully amortized. During Fiscal 2020, Dr. Lempert converted his share of the amount outstanding into common shares and the balance outstanding of $59,506 as of May 31 and February 28, 2021, respectively, is for Dresner exclusively. Dalrymple – August 2012 On August 10, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $1,000,000 of unsecured Convertible Promissory Note. The Convertible Promissory Note balance together with all accrued interest thereon was due and payable on August 10, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $310,723 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $264,462 as of May 31 and February 28, 2021, respectively. Dalrymple – October 2012 On October 2, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $500,000 of unsecured Convertible Promissory Note. This Convertible Promissory Note balance together with all accrued interest thereon was due and payable on October 2, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $137,583 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $133,178 as of May 31 and February 28, 2021, respectively. On January 30, 2017, the Company entered into an agreement entitled First Amendment to Transaction Documents with five of seven secured creditors holding a security interest in all of the Company’s assets except for its patents and other intellectual properties. All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of May 31 and February 28, 2021, respectively, plus any outstanding accrued interest.

10000

0.10

125000

0.50

24470

125000

235000

325000

90000

120000

we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company used the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. On April 1, 2021, the company received notification that the principal amount of $74,400 and accrued interest of approximately $700 were forgiven under the terms of the loan program and were recorded as a forgiveness of debt on the Condensed Statements of Operations for the three-months ended May 31, 2021. On March 3, 2021, the Company received $91,235 pursuant to Paycheck Protection Program Second Draw (“PPP2”) in accordance with legislation approved in December 2020. The terms and conditions of this loan is the same as PPP with the principal amount of $91,325 recognized as part of notes payable, non-current on the balance sheet as of May 31, 2021. Economic Injury Disaster Loan Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of May 31 and February 28, 2021, the amounts outstanding, including accrued interest of $5,224 and $3,768, respectively, are $155,125 and $153,668, respectively, and are classified as part of notes payable, non-current on the May 31 and February 28, 2021 balance sheets.

1807000

0.75

0.80

2750000 2200000 0.75 549954 549954

550000

558700

0.75

175793

163677 163677

750000

P1Y

0.75

1000000

P7Y

235985

232194 232194

200000

P1Y

0.50

39152

59506 59506

1000000

0.07

P5Y

0.05

310723

264462 264462

500000

0.07

P5Y

0.05

137583 133178 All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of May 31 and February 28, 2021, respectively, plus any outstanding accrued interest.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Non-Related Party Promissory Notes (see below)</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">May 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">February 28, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Demand promissory notes payable with Mr. Zeitlen as of May 31, 2021 and February 22, 2021, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Messrs. Abdou note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">90,181</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">120,181</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">U.S. Payroll Protection Plan loan program</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,405</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">U.S. Small Business Administration-Economic Injury Disaster Loan</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,125</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">153,668</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left">Total Demand and Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">346,541</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">358,254</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,462</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,462</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133,178</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133,178</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">945,825</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">945,825</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">59,506</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">59,506</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Convertible Promissory Notes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,402,971</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,402,971</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued Interest - convertible, demand and notes payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">259,180</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">239,038</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-Related Party</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,008,692</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,263</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Notes Payable-Related Party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,450,719</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,412,911</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Kopple Notes Payable-related party, see Kopple Notes, Note 6:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,525,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,317,787</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Mel Gagerman Note Payable, see Gagerman, Note 6:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,294</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">147,227</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">700,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">700,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Related Party</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,825,204</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,577,925</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total notes payable and accrued interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,833,896</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,578,188</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,184,565</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,015,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 4pt">Long-term portion</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,649,331</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,562,893</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

10000 10000

0.10

90181 120181 91235 74405 155125 153668 346541 358254 264462 264462

2023-01-11

0.76

0.05

133178 133178

2023-01-11

0.76

0.05

945825 945825

2023-01-11

0.75

0.05

59506 59506

2023-01-11

0.50

0.05

1402971 1402971 259180 239038 2008692 2000263

3450719

3412911

11525192

11317787

149294

147227

700000

700000 15825204 15577925 17833896 17578188

13184565

13015295

4649331

4562893

1400000

300000

3000000

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">May 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">February 28, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Accrued payroll and related expenses</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">640,729</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">547,412</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">259,180</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">239,038</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued interest-related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,719</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">412,911</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">178,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,747</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; vertical-align: top"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,529,275</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,288,107</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

640729 547412

259180

239038

450719 412911

178647

88747

1529275

1288107

NOTE 5 – SHAREHOLDERS’ EQUITY Common Stock During the three-months ended May 31, 2021, the Company issued approximately 1,865,000 shares of common stock for $283,000 in cash, respectively. During the three-months ended May 31, 2020 the Company issued approximately 1,358,000 shares of common stock for $235,000. Employee Options and Warrants The 2011 Director and Executive Officers Stock Option Plan In October 2011, shareholders approved the 2011 Director and Executive Officers Stock Option Plan at the Company’s annual meeting. Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the three-months ended May 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. On February 25, 2021 and during the fourth quarter of Fiscal 2021, the Board approved the grant of 500,000 stock options to our president with an exercise price of $0.50, vesting in equal increments over a twelve-month period and a five-year contractual term. On December 10, 2020 and during the fourth quarter of Fiscal 2021, the Board approved aggregate grants of 1,000,000 stock options to the four other board members with an exercise price of $0.25, vesting in equal increments over a twelve-month period and a five-year contractual term. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Options Issued During the Three-Months Ended May 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Options Issued During the Three-Months Ended February 28, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exercise Price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.25-$0.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.24-$0.35</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Volatility %</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Risk-Free Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.27</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.16%-0.34</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Expected Term (yrs)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Dividend Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table> The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $77,599 recorded as part of sales, general and administration expense during the three months ended May 31, 2020. The aggregate fair value of the 1,500,000 options granted in December 2020 and February 2021 is approximately $382,500, or $0.255 per option, with $146,300 recorded as part of sales, general and administration expense during the three months ended May 31, 2021. The following tables provide additional information regarding stock options outstanding and exercisable under the 2011 Director and Executive Officers Stock Option Plan for the three-months ended May 31, 2021: Directors and Officers 2011 plan <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 64%; padding-bottom: 4pt; vertical-align: top">Outstanding, February 28, 2021</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"> </td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">3,790,001</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">0.60</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">225,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Exrecised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; vertical-align: top">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; vertical-align: top">Outstanding, May 31, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,790,001</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.60</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">225,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Range of Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Options Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining Contractual Life</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Optipons Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.25 to $1.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">3,790,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">2,831,668</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">3.48</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.60</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.51</td><td style="width: 1%; text-align: left"> </td></tr> </table> Warrants Historically, warrants have been issued to investors and others for services and enticements to invest funds with the Company. Generally, these warrants fully vest immediately or within a 90-day period from the date of grant and have an expiration date of five-years from the date of grant. With grants dated prior to Fiscal 2021, an exercise price of $1.40 has been used with all warrants. No warrants were issued in the three-months ended May 31, 2021. Activity in issued and outstanding warrants is as follows for the three-months ended May 31, 2021: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center">Number of Warrants</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Outstanding, February 28, 2021</td> <td style="width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 10%; text-align: right">5,662,272</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exrecised</td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Cancelled</td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Outstanding, May 31, 2021</td> <td style="text-align: left"> </td><td style="border-top: Black 1.5pt solid; border-bottom: Black 4pt double; text-align: right">5,662,272</td><td style="text-align: left"> </td><td> </td> <td style="border-top: Black 1.5pt solid; border-bottom: Black 4pt double; text-align: left">$</td><td style="border-top: Black 1.5pt solid; border-bottom: Black 4pt double; text-align: right">1.40</td><td style="text-align: left"> </td></tr> </table> Other information related to the warrants outstanding and exercisable as of May 31, 2021 follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Range of Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining Contractual Life</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,662,272</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,662,272</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">1.48</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td></tr> </table>

1865000

283000

1358000

235000

the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the three-months ended May 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. On February 25, 2021 and during the fourth quarter of Fiscal 2021, the Board approved the grant of 500,000 stock options to our president with an exercise price of $0.50, vesting in equal increments over a twelve-month period and a five-year contractual term. On December 10, 2020 and during the fourth quarter of Fiscal 2021, the Board approved aggregate grants of 1,000,000 stock options to the four other board members with an exercise price of $0.25, vesting in equal increments over a twelve-month period and a five-year contractual term. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date: Options Issued During the Three-Months Ended May 31, 2021 Options Issued During the Three-Months Ended February 28, 2021 Exercise Price $0.50 $0.25-$0.50 Share Price $0.27 $0.24-$0.35 Volatility % 226% 226% Risk-Free Rate 0.27% 0.16%-0.34% Expected Term (yrs) 2.80 2.80 Dividend Rate 0% 0% The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $77,599 recorded as part of sales, general and administration expense during the three months ended May 31, 2020. The aggregate fair value of the 1,500,000 options granted in December 2020 and February 2021 is approximately $382,500, or $0.255 per option, with $146,300 recorded as part of sales, general and administration expense during the three months ended May 31, 2021. 0.15

250000

1250000

0.25

0.16 500000 0.50 1000000 0.25 1250000 194000 0.155

77599

1500000 382500 0.255

146300

1.40

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Options Issued During the Three-Months Ended May 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Options Issued During the Three-Months Ended February 28, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exercise Price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.25-$0.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.24-$0.35</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Volatility %</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Risk-Free Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.27</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.16%-0.34</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Expected Term (yrs)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Dividend Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table>

0.50

0.25

0.50

0.27

0.24

0.35

2.26

0.0027

0.0016

0.0034

P2Y292D

0.00

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 64%; padding-bottom: 4pt; vertical-align: top">Outstanding, February 28, 2021</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"> </td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">3,790,001</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">0.60</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">225,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Exrecised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; vertical-align: top">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; vertical-align: top">Outstanding, May 31, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,790,001</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.60</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">225,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

3790001

0.60

225000

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Range of Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Options Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining Contractual Life</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Optipons Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.25 to $1.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">3,790,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">2,831,668</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">3.48</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.60</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0.51</td><td style="width: 1%; text-align: left"> </td></tr> </table>

0.25

1.40

3790001

2831668

P3Y175D

0.60

0.51

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center">Number of Warrants</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Outstanding, February 28, 2021</td> <td style="width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 10%; text-align: right">5,662,272</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exrecised</td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Cancelled</td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Outstanding, May 31, 2021</td> <td style="text-align: left"> </td><td style="border-top: Black 1.5pt solid; border-bottom: Black 4pt double; text-align: right">5,662,272</td><td style="text-align: left"> </td><td> </td> <td style="border-top: Black 1.5pt solid; border-bottom: Black 4pt double; text-align: left">$</td><td style="border-top: Black 1.5pt solid; border-bottom: Black 4pt double; text-align: right">1.40</td><td style="text-align: left"> </td></tr> </table>

5662272

1.40

5662272

1.40

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Range of Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Stock Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining Contractual Life</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td><td style="font-weight: bold; font-style: normal; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; font-style: normal; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price of Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: normal"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,662,272</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,662,272</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">1.48</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1.40</td><td style="width: 1%; text-align: left"> </td></tr> </table>

1.40

5662272

P1Y175D

1.40

23872614

8890574

14982041

0.05

11982041

7403705

9388338

3000000

1.40

0.05

450719 412911

5607323

5917869 11525192 5710464 11317787

the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum.

82000

67294 149294 0.10 147227 700000

700000

20000

Effective February 28, 2021, we vacated both facilities and consolidated our administrative offices, operations including warehousing within a 17,700 square foot facility in Lake Forest, California under a 66-month rental agreement covering March 1, 2021 through August 31, 2026, with an initial monthly rental rate of approximately $22,000 increasing to a monthly rate of approximately $26,000 in 2026.

17700

1200000

100000

1100000

0.10

4000

1128000 1165000 161000

238000

various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company.

EX-101.SCH 6 ausi-20210531.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Shareholders’ Deficit (unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Nature of Operations And Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Related Parties Transactions link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Nature of Operations And Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Accrued Expenses (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Shareholders' Equity (Details) - Schedule of stock options outstanding link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Shareholders' Equity (Details) - Schedule of stock option exercisable link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Shareholders' Equity (Details) - Schedule of issued and outstanding warrants link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Shareholders' Equity (Details) - Schedule of warrants outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Related Parties Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Commitments & Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ausi-20210531_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ausi-20210531_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ausi-20210531_lab.xml XBRL LABEL FILE Statement of Financial Position [Abstract] Total current assets Total assets Total current liabilities Total liabilities Total shareholders’ deficit Balance Balance Total liabilities and shareholders’ deficit Income Statement [Abstract] Gross profit (loss) Total operating expenses Loss from operations Loss before tax provision Net loss Net loss Statement of Cash Flows [Abstract] Cash used in operating activities Cash provided by financing activities Net increase (decrease) in cash and cash equivalents Beginning cash Ending cash Statement of Stockholders' Equity [Abstract] Balance (in Shares) Balance (in Shares) Equity Components [Axis] Accounting Policies [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Debt Disclosure [Abstract] Schedule of non-related party and related party notes payable transaction [Abstract] Debt Instrument [Axis] Related Party [Axis] Payables and Accruals [Abstract] Schedule of accrued expenses [Abstract] Stockholders' Equity Note [Abstract] Plan Name [Axis] Schedule of fair value of the stock options as of the grant date [Abstract] Statistical Measurement [Axis] Schedule of stock options outstanding [Abstract] Schedule of stock option exercisable [Abstract] Schedule of issued and outstanding warrants [Abstract] Number of Warrant, Outstanding beginning balance Number of Warrant, Outstanding ending balance Exercise Price, Outstanding beginning balance Exercise Price, Outstanding ending balance Schedule of warrants outstanding and exercisable [Abstract] Related Party Transactions [Abstract] Commitments and Contingencies Disclosure [Abstract] Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Emerging Growth Company Entity File Number Entity Filer Category Entity Incorporation, State or Country Code Entity Interactive Data Current Entity Registrant Name Entity Shell Company Entity Small Business Assets Cash and cash equivalents Inventory Other current assets Fixed Assets, net Right-of-use asset Operating lease liability Deposit Liabilities & Shareholders’ Deficit Current liabilities Accounts payable Accrued expenses Customer advances Operating lease liability Notes payable, current portion Notes payable and accrued interest-related party Convertible note payable-related party Notes payable-related party, non-current Notes payable, non-current Convertible notes payable Operating lease liability, non-current Commitments and contingencies (Note 7) Shareholders’ deficit Common stock: $0.0001 par value; 150,000,000 shares authorized at May 31, 2021 and February 28, 2021; 72,972,775 and 71,107,442 issued and outstanding at May 31, 2021 and February 28, 2021, respectively. common stock Value Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Additional paid-in capital Accumulated deficit Net revenue Cost of goods sold Operating expenses Engineering, research & development Selling, general & administration Other (income) expense: Interest expense, net Forgiveness of PPP loan Income tax provision Basic and diluted loss per share (in Dollars per share) Basic and diluted weighted-average shares outstanding (in Shares) Adjustments to reconcile net loss to cash used in operating activities Depreciation Stock-based compensation expense Changes in working capital assets and liabilities: Accounts payable and accrued expenses Accrued interest on notes payable Cash used in investing activities: Cash flows from financing activities: Issuance of common stock Proceeds from Federal PPP loans Cash paid in the period for: Interest Income taxes Shares issued for cash Shares issued for cash (in Shares) Stock-based compensation expense Gain on debt settlement Other income Gain on write-off of liabilities Forgiveness of PPP loan Inventory Other current assets Operating lease liability Purchase of property, plant and equipment Payments of notes payable Common Stock Common Stock [Member] Additional Paid-In Capital Accumulated Deficit NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN NOTES PAYABLE Schedule of non-related party and related party notes payable transaction Demand and Notes Payble Notes payable interest rate Total Demand and Notes Payable Convertible Promissory Notes Converted instrument date Common stock at price (in Dollars per share) Total Convertible Promissory Notes Accrued Interest - convertible, demand and notes payable Total Non-Related Party Notes Payable-Related Party Convertible notes payable Convertible notes payable (in Dollars) Total Related Party Total notes payable and accrued interest Long-term portion ACCRUED EXPENSES Schedule of accrued expenses Accrued payroll and related expenses Accrued interest Accrued interest-related party Other accrued expenses Total SHAREHOLDERS’ EQUITY Schedule of fair value of the stock options as of the grant date Exercise Price (in Dollars per share) Range of Exercise Price Share Price (in Dollars per share) Volatility % Risk-Free Rate Expected Term (yrs) Dividend Rate Schedule of stock options outstanding Number of options ,Outstanding, bginning balance (in Shares) Number of options ,Outstanding, ending balance (in Shares) Stock Warrants Outstanding (in Shares) Exercise Price,Outstanding, bginning balance Exercise Price, Outstanding, ending balance Weighted Average Intrinsic Value, Outstanding, bginning balance (in Dollars) Weighted Average Intrinsic Value, Outstanding, ending balance (in Dollars) Number of options ,Granted (in Shares) Stock options granted (in Shares) Exercise Price, Granted Exercise Price, Exrecised Weighted Average Intrinsic Value, Granted Number of options ,Exrecised (in Shares) Stock Warrants Exercisable (in Shares) Weighted Average Intrinsic Value, Exrecised (in Dollars) Number of options ,Cancelled (in Shares) Exercise Price, Cancelled Weighted Average Intrinsic Value, Cancelled Schedule of stock option exercisable Stock Options Outstanding (in Shares) Stock Options Exercisable (in Shares) Weighted Average Remaining Contractual Life Weighted Average Exercise Price of Options Outstanding Weighted Average Exercise Price of Optipons Exercisable Schedule of issued and outstanding warrants Number of Warrant, Granted Exercise Price, Granted Number of Warrant, Exrecised Exercise Price, Exrecised Number of Warrant, Cancelled Exercise Price, Cancelled EX-101.PRE 10 ausi-20210531_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	May 31, 2021	Jul. 12, 2021
Document Information Line Items
Entity Registrant Name	AURA SYSTEMS INC
Document Type	10-Q
Current Fiscal Year End Date	--02-28
Entity Common Stock, Shares Outstanding		72,988,343
Amendment Flag	false
Entity Central Index Key	0000826253
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	May 31, 2021
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	0-17249
Entity Incorporation, State or Country Code	DE
Entity Interactive Data Current	No

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Unaudited) - USD ($)	May 31, 2021	Feb. 28, 2021
Assets
Cash and cash equivalents	$ 187,702	$ 390,702
Inventory	124,529	94,166
Other current assets	91,751	115,202
Total current assets	403,982	600,070
Fixed Assets, net	30,620	14,870
Right-of-use asset	1,127,670	1,168,053
Deposit	159,595	159,595
Total assets	1,721,868	1,942,589
Current liabilities
Accounts payable	1,892,923	1,880,172
Accrued expenses	1,529,273	1,288,107
Customer advances	440,331	440,331
Operating lease liability	160,742	110,587
Notes payable, current portion	100,181	198,331
Notes payable and accrued interest-related party	12,374,486	12,165,015
Total current liabilities	16,497,936	16,082,543
Convertible note payable-related party	3,000,000	3,000,000
Notes payable, non-current	246,360	159,922
Convertible notes payable	1,402,971	1,402,971
Operating lease liability, non-current	1,003,897	1,046,902
Total liabilities	22,151,163	21,692,339
Commitments and contingencies (Note 7)
Shareholders’ deficit
Common stock: $0.0001 par value; 150,000,000 shares authorized at May 31, 2021 and February 28, 2021; 72,972,775 and 71,107,442 issued and outstanding at May 31, 2021 and February 28, 2021, respectively.	7,297	7,111
Additional paid-in capital	446,555,737	446,126,638
Accumulated deficit	(466,992,329)	(465,883,499)
Total shareholders’ deficit	(20,429,295)	(19,749,750)
Total liabilities and shareholders’ deficit	$ 1,721,868	$ 1,942,589

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Unaudited) (Parentheticals) - $ / shares	May 31, 2021	Feb. 28, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	72,972,775	71,107,442
Common stock, shares outstanding	72,972,775	71,107,442

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	May 31, 2021	May 31, 2020
Income Statement [Abstract]
Net revenue	$ 23,937	$ 48,633
Cost of goods sold	49,311	40,393
Gross profit (loss)	(25,374)	8,240
Operating expenses
Engineering, research & development	80,595	33,994
Selling, general & administration	812,681	343,559
Total operating expenses	893,276	377,553
Loss from operations	(918,650)	(369,313)
Other (income) expense:
Interest expense, net	269,575	289,688
Gain on debt settlement	(4,292)	(46,000)
Forgiveness of PPP loan	(75,104)
Other income		(7,000)
Loss before tax provision	(1,108,829)	(606,001)
Income tax provision
Net loss	$ (1,108,829)	$ (606,001)
Basic and diluted loss per share (in Dollars per share)	$ (0.02)	$ (0.01)
Basic and diluted weighted-average shares outstanding (in Shares)	71,932,398	57,072,794

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	May 31, 2021	May 31, 2020
Statement of Cash Flows [Abstract]
Net loss	$ (1,108,829)	$ (606,001)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation	772
Gain on write-off of liabilities	(4,292)
Forgiveness of PPP loan	(75,104)
Stock-based compensation expense	146,284	77,599
Changes in working capital assets and liabilities:
Inventory	(30,363)	931
Other current assets	23,452	1,070
Accounts payable and accrued expenses	199,562	55,742
Accrued interest on notes payable	270,274	289,622
Operating lease liability	47,532
Cash used in operating activities	(530,713)	(181,037)
Cash used in investing activities:
Purchase of property, plant and equipment	(16,522)
Cash flows from financing activities:
Issuance of common stock	283,000	235,000
Payments of notes payable	(30,000)	(10,000)
Proceeds from Federal PPP loans	91,235	74,405
Cash provided by financing activities	344,235	299,405
Net increase (decrease) in cash and cash equivalents	(202,999)	118,368
Beginning cash	390,702	19,807
Ending cash	187,702	138,174
Cash paid in the period for:
Interest
Income taxes

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Statements of Shareholders’ Deficit (unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Feb. 29, 2020	$ 5,639	$ 443,417,452	$ (466,726,027)	$ (23,302,937)
Balance (in Shares) at Feb. 29, 2020	56,400,874
Shares issued for cash	$ 135	234,865		235,000
Shares issued for cash (in Shares)	1,358,333
Stock-based compensation expense		77,599		77,599
Net loss			(606,001)	(606,001)
Balance at May. 31, 2020	$ 5,774	443,729,916	(467,332,029)	(23,596,339)
Balance (in Shares) at May. 31, 2020	57,759,207
Balance at Feb. 28, 2021	$ 7,111	446,126,638	(465,883,499)	(19,749,750)
Balance (in Shares) at Feb. 28, 2021	71,107,442
Shares issued for cash	$ 186	282,815		283,001
Shares issued for cash (in Shares)	1,865,333
Stock-based compensation expense		146,284		146,284
Net loss			(1,108,829)	(1,108,829)
Balance at May. 31, 2021	$ 7,297	$ 446,555,737	$ (466,992,328)	$ (20,429,295)
Balance (in Shares) at May. 31, 2021	72,972,775

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 17 R7.htm IDEA: XBRL DOCUMENT

Nature of Operations And Summary of Significant Accounting Policies

3 Months Ended

May 31, 2021

Accounting Policies [Abstract]

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Basis of Presentation

Significant Accounting Policies

Use of Estimates

Recently Issued Accounting Pronouncements

XML 18 R8.htm IDEA: XBRL DOCUMENT

Going Concern

3 Months Ended

May 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN

NOTE 2 – GOING CONCERN

XML 19 R9.htm IDEA: XBRL DOCUMENT

Notes Payable

3 Months Ended

May 31, 2021

Debt Disclosure [Abstract]

NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

Non-related party and related party notes payable principal and accrued interest amounts consisted of the following:

Non-Related Party Promissory Notes (see below)	May 31, 2021			February 28, 2021
Demand promissory notes payable with Mr. Zeitlen as of May 31, 2021 and February 22, 2021, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)	$	10,000		$	10,000
Messrs. Abdou note payable		90,181			120,181
U.S. Payroll Protection Plan loan program		91,235			74,405
U.S. Small Business Administration-Economic Injury Disaster Loan		155,125			153,668
Total Demand and Notes Payable		346,541			358,254

Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.		264,462			264,462
Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.		133,178			133,178
Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.		945,825			945,825
Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.		59,506			59,506
Total Convertible Promissory Notes		1,402,971			1,402,971

Accrued Interest - convertible, demand and notes payable		259,180			239,038
Total Non-Related Party		2,008,692			2,000,263

Notes Payable-Related Party
Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details		3,450,719			3,412,911
Kopple Notes Payable-related party, see Kopple Notes, Note 6:		11,525,192			11,317,787
Mel Gagerman Note Payable, see Gagerman, Note 6:		149,294			147,227
On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.		700,000			700,000
Total Related Party		15,825,204			15,577,925
Total notes payable and accrued interest		17,833,896			17,578,188
Less: Current portion	$	(13,184,565	)	$	(13,015,295	)
Long-term portion	$	4,649,331		$	4,562,893

Demand Promissory Note

Abdou and Abdou

Paycheck Protection Plan Loans

Economic Injury Disaster Loan

Convertible Notes Payable

Kenmont Capital Partners

LPD Investments

Guenther

Dresner and Lempert

Dalrymple – August 2012

Dalrymple – October 2012

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 20 R10.htm IDEA: XBRL DOCUMENT

Accrued Expenses

3 Months Ended

May 31, 2021

Payables and Accruals [Abstract]

ACCRUED EXPENSES

NOTE 4 – ACCRUED EXPENSES

Accrued expenses consisted of the following as of the periods referenced below:

	May 31, 2021		February 28, 2021
Accrued payroll and related expenses		640,729		547,412
Accrued interest		259,180		239,038
Accrued interest-related party		450,719		412,911
Other accrued expenses		178,647		88,747
	$	1,529,275	$	1,288,107

XML 21 R11.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

3 Months Ended

May 31, 2021

Stockholders' Equity Note [Abstract]

SHAREHOLDERS’ EQUITY

NOTE 5 – SHAREHOLDERS’ EQUITY

Common Stock

Employee Options and Warrants

The 2011 Director and Executive Officers Stock Option Plan

	Options Issued During the Three-Months Ended May 31, 2021			Options Issued During the Three-Months Ended February 28, 2021
Exercise Price	$	0.50		$	0.25-$0.50
Share Price	$	0.27		$	0.24-$0.35
Volatility %		226	%		226	%
Risk-Free Rate		0.27	%		0.16%-0.34	%
Expected Term (yrs)		2.80			2.80
Dividend Rate		0	%		0	%

Directors and Officers 2011 plan

	Number of Options		Exercise Price		Weighted Average Intrinsic Value
Outstanding, February 28, 2021		3,790,001	$	0.60	$	225,000
Granted		-		-		-
Exrecised		-		-		-
Cancelled		-		-		-
Outstanding, May 31, 2021		3,790,001	$	0.60	$	225,000

Range of Exercise Price				Stock Options Outstanding				Stock Options Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Options Outstanding				Weighted Average Exercise Price of Optipons Exercisable
$	0.25 to $1.40				3,790,001				2,831,668				3.48			$	0.60			$	0.51

Warrants

Activity in issued and outstanding warrants is as follows for the three-months ended May 31, 2021:

	Number of Warrants		Exercise Price
Outstanding, February 28, 2021	5,662,272	$	1.40
Granted	-		-
Exrecised	-		-
Cancelled	-		-
Outstanding, May 31, 2021	5,662,272	$	1.40

Other information related to the warrants outstanding and exercisable as of May 31, 2021 follows:

Range of Exercise Price				Stock Warrants Outstanding				Stock Warrants Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Warrants Outstanding				Weighted Average Exercise Price of Warrants Exercisable
$	1.40				5,662,272				5,662,272				1.48			$	1.40			$	1.40

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 22 R12.htm IDEA: XBRL DOCUMENT

Related Parties Transactions

3 Months Ended

May 31, 2021

RELATED PARTIES TRANSACTIONS

NOTE 6 – RELATED PARTIES TRANSACTIONS

Notes payable-related party, non-current - $3,000,000 on the condensed balance sheets as of May 31 and February 28, 2021 consists of the Breslow Note as described below:

Breslow Note

Kopple Notes

Gagerman Note

Jiangsu Shengfeng Note

XML 23 R13.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies

3 Months Ended

May 31, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS & CONTINGENCIES

NOTE 7 – COMMITMENTS & CONTINGENCIES

Leases

Contingencies

XML 24 R14.htm IDEA: XBRL DOCUMENT

Accounting Policies, by Policy (Policies)	3 Months Ended
Accounting Policies, by Policy (Policies)	May 31, 2021
Accounting Policies [Abstract]
Nature of Operations	*Nature of Operations* Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, was founded to engage in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen^®axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets.
Basis of Presentation	*Basis of Presentation* In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results. The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2021 (“Fiscal 2021”) filed with the Securities and Exchange Commission (“SEC”) on June 1, 2021 (“2021 Form 10-K.”). Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2022; we refer to the current fiscal as Fiscal 2022. The prior fiscal year is Fiscal 2021.
Significant Accounting Policies	*Significant Accounting Policies* For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in our financial statements included in Company’s 2021 Form 10-K.
Use of Estimates	*Use of Estimates* The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Recently Issued Accounting Pronouncements	*Recently Issued Accounting Pronouncements* In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects adoption will have on its financial statements. In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40), (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU2020-06 amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its financial statements.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

3 Months Ended

May 31, 2021

Debt Disclosure [Abstract]

Schedule of non-related party and related party notes payable transaction

Non-Related Party Promissory Notes (see below)	May 31, 2021			February 28, 2021
Demand promissory notes payable with Mr. Zeitlen as of May 31, 2021 and February 22, 2021, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)	$	10,000		$	10,000
Messrs. Abdou note payable		90,181			120,181
U.S. Payroll Protection Plan loan program		91,235			74,405
U.S. Small Business Administration-Economic Injury Disaster Loan		155,125			153,668
Total Demand and Notes Payable		346,541			358,254

Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.		264,462			264,462
Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.		133,178			133,178
Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.		945,825			945,825
Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.		59,506			59,506
Total Convertible Promissory Notes		1,402,971			1,402,971

Accrued Interest - convertible, demand and notes payable		259,180			239,038
Total Non-Related Party		2,008,692			2,000,263

Notes Payable-Related Party
Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details		3,450,719			3,412,911
Kopple Notes Payable-related party, see Kopple Notes, Note 6:		11,525,192			11,317,787
Mel Gagerman Note Payable, see Gagerman, Note 6:		149,294			147,227
On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.		700,000			700,000
Total Related Party		15,825,204			15,577,925
Total notes payable and accrued interest		17,833,896			17,578,188
Less: Current portion	$	(13,184,565	)	$	(13,015,295	)
Long-term portion	$	4,649,331		$	4,562,893

XML 26 R16.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

3 Months Ended

May 31, 2021

Payables and Accruals [Abstract]

Schedule of accrued expenses

	May 31, 2021		February 28, 2021
Accrued payroll and related expenses		640,729		547,412
Accrued interest		259,180		239,038
Accrued interest-related party		450,719		412,911
Other accrued expenses		178,647		88,747
	$	1,529,275	$	1,288,107

XML 27 R17.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Tables)

3 Months Ended

May 31, 2021

Shareholders' Equity (Tables) [Line Items]

Schedule of issued and outstanding warrants

	Number of Warrants		Exercise Price
Outstanding, February 28, 2021	5,662,272	$	1.40
Granted	-		-
Exrecised	-		-
Cancelled	-		-
Outstanding, May 31, 2021	5,662,272	$	1.40

Schedule of warrants outstanding and exercisable

Range of Exercise Price				Stock Warrants Outstanding				Stock Warrants Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Warrants Outstanding				Weighted Average Exercise Price of Warrants Exercisable
$	1.40				5,662,272				5,662,272				1.48			$	1.40			$	1.40

Two Thousand Eleven Director and Executive Officers Stock Option Plan [Member]

Shareholders' Equity (Tables) [Line Items]

Schedule of fair value of the stock options as of the grant date

	Options Issued During the Three-Months Ended May 31, 2021			Options Issued During the Three-Months Ended February 28, 2021
Exercise Price	$	0.50		$	0.25-$0.50
Share Price	$	0.27		$	0.24-$0.35
Volatility %		226	%		226	%
Risk-Free Rate		0.27	%		0.16%-0.34	%
Expected Term (yrs)		2.80			2.80
Dividend Rate		0	%		0	%

Schedule of stock options outstanding

	Number of Options		Exercise Price		Weighted Average Intrinsic Value
Outstanding, February 28, 2021		3,790,001	$	0.60	$	225,000
Granted		-		-		-
Exrecised		-		-		-
Cancelled		-		-		-
Outstanding, May 31, 2021		3,790,001	$	0.60	$	225,000

Schedule of stock option exercisable

Range of Exercise Price				Stock Options Outstanding				Stock Options Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Options Outstanding				Weighted Average Exercise Price of Optipons Exercisable
$	0.25 to $1.40				3,790,001				2,831,668				3.48			$	0.60			$	0.51

XML 28 R18.htm IDEA: XBRL DOCUMENT

Going Concern (Details) $ in Millions	3 Months Ended
Going Concern (Details) $ in Millions	May 31, 2021 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 1.1
Operating activities	$ 0.5

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

XML 29 R19.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - USD ($)						1 Months Ended						3 Months Ended	12 Months Ended
Notes Payable (Details) - USD ($)	Oct. 02, 2021	Jan. 11, 2018	Aug. 10, 2017	May 07, 2013	Aug. 10, 2012	Feb. 28, 2021	Apr. 23, 2020	Sep. 30, 2018	Jan. 30, 2017	Oct. 31, 2016	Jun. 20, 2013	May 31, 2021	Feb. 28, 2021	Feb. 28, 2019	Sep. 30, 2015	Sep. 25, 2013
Notes Payable (Details) [Line Items]
Paycheck protection plan loan, Description							we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company used the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. On April 1, 2021, the company received notification that the principal amount of $74,400 and accrued interest of approximately $700 were forgiven under the terms of the loan program and were recorded as a forgiveness of debt on the Condensed Statements of Operations for the three-months ended May 31, 2021. On March 3, 2021, the Company received $91,235 pursuant to Paycheck Protection Program Second Draw (“PPP2”) in accordance with legislation approved in December 2020. The terms and conditions of this loan is the same as PPP with the principal amount of $91,325 recognized as part of notes payable, non-current on the balance sheet as of May 31, 2021. Economic Injury Disaster Loan Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of May 31 and February 28, 2021, the amounts outstanding, including accrued interest of $5,224 and $3,768, respectively, are $155,125 and $153,668, respectively, and are classified as part of notes payable, non-current on the May 31 and February 28, 2021 balance sheets.
Demand Promissory Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt amount						$ 10,000						$ 10,000	$ 10,000
Notes payable interest rate						10.00%						10.00%	10.00%		10.00%
Kenmont Capital Partners [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt amount				$ 1,807,000
Notes payable interest rate												80.00%
Conversion price per share of notes payable (in Dollars per share)												$ 0.75
Remaining balance												$ 549,954	$ 549,954
Accrued interest amount										$ 2,750,000
Principle amount										$ 2,200,000
ConversionPricePerShare (in Dollars per share)										$ 0.75
LPD Investments, Ltd. [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt amount				558,700
Pre conversion debt principal amount				550,000
Conversion price per share of notes payable (in Dollars per share)												$ 0.75
Amortization of debt discount												$ 175,793
Remaining balance												163,677	163,677
Abdou and Abdou [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount								$ 325,000			$ 125,000	90,000	120,000
Conversion price per share of notes payable (in Dollars per share)											$ 0.50
Amortization of debt discount											$ 24,470
Remaining balance														$ 125,000
Amount of accrued interest											125,000
Judgment of approximately value plus legal fees								$ 235,000
Kenmont Capital Partners [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Debt amount																$ 1,807,000
Guenther [Member] \| Refinancing Agreements [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount				$ 750,000
Conversion price per share of notes payable (in Dollars per share)				$ 0.75
Amortization of debt discount				$ 235,985
Remaining balance												232,194	232,194
Notes maturity date, term				1 year
Number of common shares entitlement on exercise of warrant one (in Shares)				1,000,000
Term of warrant				7 years
Dresner and Lempert [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount											$ 200,000
Conversion price per share of notes payable (in Dollars per share)											$ 0.50
Amortization of debt discount												39,152
Remaining balance						$ 59,506						59,506
Notes maturity date, term											1 year
Dalrymple [Member] \| Refinancing Agreements [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Notes payable interest rate		5.00%
Dalrymple [Member] \| Unsecured Debt [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Notes payable interest rate		5.00%	7.00%
Pre conversion debt principal amount					$ 1,000,000
Amortization of debt discount												310,723
Remaining balance		$ 137,583										$ 264,462	133,178
Dalrymple [Member] \| Unsecured Debt [Member] \| Convertible Debt [Member]
Notes Payable (Details) [Line Items]
Notes maturity date, term			5 years
Convertible Notes Payable Description									All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of May 31 and February 28, 2021, respectively, plus any outstanding accrued interest.
Dalrymple [Member] \| Convertible Notes Payable [Member] \| Unsecured Debt [Member]
Notes Payable (Details) [Line Items]
Notes payable interest rate	7.00%
Pre conversion debt principal amount	$ 500,000
Remaining balance													$ 264,462
Notes maturity date, term	5 years

XML 30 R20.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction - USD ($)	May 31, 2021	Feb. 28, 2021
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Accrued Interest - convertible, demand and notes payable	$ 259,180	$ 239,038
Total Non-Related Party	2,008,692	2,000,263
Jiangsu Shengfeng [Member]
Notes Payable-Related Party
Convertible notes payable	700,000	700,000
Total Related Party	15,825,204	15,577,925
Total notes payable and accrued interest	17,833,896	17,578,188
Less: Current portion	(13,184,565)	(13,015,295)
Long-term portion	4,649,331	4,562,893
Demand Promissory Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	10,000	10,000
Messrs. Abdou note payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	90,181	120,181
U.S. Payroll Protection Plan loan program [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	91,235	74,405
U.S. Small Business Administration-Economic Injury Disaster Loan [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	155,125	153,668
Total Demand and Notes Payable	346,541	358,254
Convertible Promissory Note dated August 10, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	264,462	264,462
Convertible Promissory Note originally dated October 2, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	133,178	133,178
Senior secured convertible notes originally dated May 7, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	945,825	945,825
Senior secured convertible notes originally dated June 20, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	59,506	59,506
Total Convertible Promissory Notes	1,402,971	1,402,971
Notes Payable [Member]
Notes Payable-Related Party
Convertible notes payable	3,450,719	3,412,911
Kopple Notes Payable-related party [Member]
Notes Payable-Related Party
Convertible notes payable	11,525,192	11,317,787
Mel Gagerman Note Payable [Member]
Notes Payable-Related Party
Convertible notes payable	$ 149,294	$ 147,227

XML 31 R21.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) - USD ($)	3 Months Ended
	May 31, 2021	Feb. 28, 2021	Sep. 30, 2015
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Common stock at price (in Dollars per share)	$ 1,250,000
Jiangsu Shengfeng [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Convertible notes payable (in Dollars)	$ 700,000
Demand Promissory Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	10.00%	10.00%	10.00%
Convertible Promissory Note dated August 10, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.76
Convertible Promissory Note originally dated October 2, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.76
Senior secured convertible notes originally dated May 7, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.75
Senior secured convertible notes originally dated June 20, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.50

XML 32 R22.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Details) $ in Millions	May 31, 2021 USD ($)
Payables and Accruals [Abstract]
Convertible promissory notes	$ 1.4
Other promissory notes	0.3
Principal amount	$ 3.0

XML 33 R23.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Details) - Schedule of accrued expenses - USD ($)	3 Months Ended
	May 31, 2021	Feb. 28, 2021
Schedule of accrued expenses [Abstract]
Accrued payroll and related expenses	$ 640,729	$ 547,412
Accrued interest	259,180	239,038
Accrued interest-related party	450,719	412,911
Other accrued expenses	178,647	88,747
Total	$ 1,529,275	$ 1,288,107

XML 34 R24.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - USD ($)		1 Months Ended		3 Months Ended			12 Months Ended
Shareholders' Equity (Details) - USD ($)	Dec. 10, 2020	Feb. 25, 2021	Dec. 31, 2020	May 31, 2021	May 31, 2020	Mar. 31, 2020	Feb. 28, 2021	Mar. 19, 2019	Oct. 01, 2011
Stockholders' Equity Note [Abstract]
Issuance of common stock (in Shares)				1,865,000
Shares of common stock				$ 283,000
Common stock shares issued					$ 1,358,000
common stock Value				$ 7,297	235,000		$ 7,111
Employee Stock Option Plan Description				the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the three-months ended May 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. On February 25, 2021 and during the fourth quarter of Fiscal 2021, the Board approved the grant of 500,000 stock options to our president with an exercise price of $0.50, vesting in equal increments over a twelve-month period and a five-year contractual term. On December 10, 2020 and during the fourth quarter of Fiscal 2021, the Board approved aggregate grants of 1,000,000 stock options to the four other board members with an exercise price of $0.25, vesting in equal increments over a twelve-month period and a five-year contractual term. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date: Options Issued During the Three-Months Ended May 31, 2021 Options Issued During the Three-Months Ended February 28, 2021 Exercise Price $0.50 $0.25-$0.50 Share Price $0.27 $0.24-$0.35 Volatility % 226% 226% Risk-Free Rate 0.27% 0.16%-0.34% Expected Term (yrs) 2.80 2.80 Dividend Rate 0% 0% The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $77,599 recorded as part of sales, general and administration expense during the three months ended May 31, 2020. The aggregate fair value of the 1,500,000 options granted in December 2020 and February 2021 is approximately $382,500, or $0.255 per option, with $146,300 recorded as part of sales, general and administration expense during the three months ended May 31, 2021.
Stock options Granted									15.00%
Stock options granted (in Shares)				250,000
Common stock at price (in Dollars per share)				$ 1,250,000
Exercise price				$ 0.25
Market price per share (in Dollars per share)								$ 0.16
Granted stock options (in Shares)	1,000,000	500,000	1,500,000			1,250,000
Exercise price of options (in Dollars per share)	$ 0.25	$ 0.50		$ 1.40
Granted stock options, fair value				$ 194,000			$ 382,500
Stock Options Per Share (in Dollars per share)				$ 0.155			$ 0.255
Sales, general and administration expense				$ 146,300	$ 77,599

XML 35 R25.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date - Two Thousand Eleven Director and Executive Officers Stock Option Plan [Member] - $ / shares	3 Months Ended
	May 31, 2021	Feb. 28, 2021
Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date [Line Items]
Exercise Price (in Dollars per share)	$ 0.50
Share Price (in Dollars per share)	$ 0.27
Volatility %	226.00%	226.00%
Risk-Free Rate	0.27%
Expected Term (yrs)	2 years 292 days	2 years 292 days
Dividend Rate	0.00%	0.00%
Minimum [Member]
Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date [Line Items]
Exercise Price (in Dollars per share)		$ 0.25
Share Price (in Dollars per share)		$ 0.24
Risk-Free Rate		0.16%
Maximum [Member]
Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date [Line Items]
Exercise Price (in Dollars per share)		$ 0.50
Share Price (in Dollars per share)		$ 0.35
Risk-Free Rate		0.34%

XML 36 R26.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of stock options outstanding - Directors and Officers 2011 plan [Member]	3 Months Ended
	May 31, 2021 USD ($) $ / shares shares
Shareholders' Equity (Details) - Schedule of stock options outstanding [Line Items]
Number of options ,Outstanding, bginning balance (in Shares) \| shares	3,790,001
Exercise Price,Outstanding, bginning balance	$ 0.60
Weighted Average Intrinsic Value, Outstanding, bginning balance (in Dollars) \| $	$ 225,000
Number of options ,Granted (in Shares) \| shares
Exercise Price, Granted
Weighted Average Intrinsic Value, Granted
Number of options ,Exrecised (in Shares) \| shares
Exercise Price, Exrecised
Weighted Average Intrinsic Value, Exrecised (in Dollars) \| $
Number of options ,Cancelled (in Shares) \| shares
Exercise Price, Cancelled
Weighted Average Intrinsic Value, Cancelled
Number of options ,Outstanding, ending balance (in Shares) \| shares	3,790,001
Exercise Price, Outstanding, ending balance	$ 0.60
Weighted Average Intrinsic Value, Outstanding, ending balance (in Dollars) \| $	$ 225,000

XML 37 R27.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of stock option exercisable - Directors and Officers 2011 plan [Member]	3 Months Ended
	May 31, 2021 $ / shares shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding (in Shares) \| shares	3,790,001
Stock Options Exercisable (in Shares) \| shares	2,831,668
Weighted Average Remaining Contractual Life	3 years 175 days
Weighted Average Exercise Price of Options Outstanding	$ 0.60
Weighted Average Exercise Price of Optipons Exercisable	0.51
Minimum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Price	0.25
Maximum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Price	$ 1.40

XML 38 R28.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of issued and outstanding warrants	3 Months Ended
	May 31, 2021 $ / shares shares
Schedule of issued and outstanding warrants [Abstract]
Number of Warrant, Outstanding beginning balance \| shares	5,662,272
Exercise Price, Outstanding beginning balance \| $ / shares	$ 1.40
Number of Warrant, Granted \| $ / shares
Exercise Price, Granted \| shares
Number of Warrant, Exrecised \| shares
Exercise Price, Exrecised \| $ / shares
Number of Warrant, Cancelled \| shares
Exercise Price, Cancelled \| $ / shares
Number of Warrant, Outstanding ending balance \| shares	5,662,272
Exercise Price, Outstanding ending balance \| $ / shares	$ 1.40

XML 39 R29.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of warrants outstanding and exercisable	3 Months Ended
	May 31, 2021 $ / shares shares
Schedule of warrants outstanding and exercisable [Abstract]
Range of Exercise Price	$ 1.40
Stock Warrants Outstanding (in Shares) \| shares	5,662,272
Stock Warrants Exercisable (in Shares) \| shares	5,662,272
Weighted Average Remaining Contractual Life	1 year 175 days
Weighted Average Exercise Price of Warrants Outstanding	$ 1.40
Weighted Average Exercise Price of Warrants Exercisable	$ 1.40

XML 40 R30.htm IDEA: XBRL DOCUMENT

Related Parties Transactions (Details) - USD ($)	1 Months Ended						3 Months Ended		12 Months Ended
Related Parties Transactions (Details) - USD ($)	May 31, 2021	Feb. 28, 2021	Nov. 20, 2019	Feb. 14, 2018	Jan. 24, 2017	Aug. 19, 2013	May 31, 2021	Feb. 28, 2021	Feb. 28, 2021
Related Parties Transactions (Details) [Line Items]
Notes payable-related party, non-current	$ 3,000,000	$ 3,000,000					$ 3,000,000	$ 3,000,000	$ 3,000,000
Accrued interest-related party							450,719	412,911
Notes payable and accrued interest-related party	12,374,486	12,165,015					12,374,486	12,165,015	12,165,015
Jiangsu Shengfeng [Member]
Related Parties Transactions (Details) [Line Items]
Companies return			$ 700,000
Principle loan amount			$ 700,000
Common Stock [Member]
Related Parties Transactions (Details) [Line Items]
Number of shares converted by notes (in Shares)				7,403,705
Mr. Breslow [Member]
Related Parties Transactions (Details) [Line Items]
Debt instrument principle amount					$ 23,872,614
Accrued interest on debt					8,890,574
Amount of convertible notes				$ 3,000,000	$ 14,982,041
Percentage of interest on notes				5.00%
Amount of notes converted				$ 11,982,041
Accrued interest on convertible notes				$ 9,388,338					412,911
Convertible rate price (in Dollars per share)				$ 1.40
Accrued interest-related party	450,719
Mr. Breslow [Member] \| Convertible Note [Member]
Related Parties Transactions (Details) [Line Items]
Percentage of interest on notes					5.00%
Robert Kopple [Member]
Related Parties Transactions (Details) [Line Items]
Debt instrument principle amount	5,607,323						5,607,323
Accrued interest on notes	5,917,869	5,710,464
Balance of principle and accrued interest	11,525,192	11,317,787					11,525,192	11,317,787	11,317,787
Related party transaction, description						the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum.
Melvin Gagerman [Member] \| Unsecured Debt [Member]
Related Parties Transactions (Details) [Line Items]
Accrued interest on notes	67,294
Unsecured note payable	82,000						82,000
Total amount of unsecured notes payable and accrued interest	$ 149,294	$ 147,227					$ 149,294	$ 147,227	$ 147,227
Percentage of interest accrue		10.00%

XML 41 R31.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies (Details)	1 Months Ended	3 Months Ended	12 Months Ended
Commitments & Contingencies (Details)	Mar. 26, 2019	May 31, 2021 USD ($) m²	Feb. 28, 2021 USD ($) m²
Commitments & Contingencies (Details) [Line Items]
Area of facility (in Square Meters) \| m²		20,000	17,700
Initial monthly rental		Effective February 28, 2021, we vacated both facilities and consolidated our administrative offices, operations including warehousing within a 17,700 square foot facility in Lake Forest, California under a 66-month rental agreement covering March 1, 2021 through August 31, 2026, with an initial monthly rental rate of approximately $22,000 increasing to a monthly rate of approximately $26,000 in 2026.
Operating lease liability		$ 1,127,670	$ 1,168,053
Lease discount rate			10.00%
Asset balance		1,128,000
Total lease liability		1,165,000
Lease current liability		161,000
ROU [Member]
Commitments & Contingencies (Details) [Line Items]
Operating lease liability			$ 1,200,000
Lease current liability			100,000
Lease non current liability			1,100,000
Operating expenses per month			$ 4,000
Director [Member]
Commitments & Contingencies (Details) [Line Items]
Contingencies, description	various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company.
Stanton Facility [Member]
Commitments & Contingencies (Details) [Line Items]
Accrued salary and related charges		$ 238,000

EXCEL 42 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 135 297 1 false 40 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://aurasystems.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://aurasystems.com/role/ConsolidatedBalanceSheet Condensed Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Unaudited) (Parentheticals) Sheet http://aurasystems.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://aurasystems.com/role/ConsolidatedIncomeStatement Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://aurasystems.com/role/ConsolidatedCashFlow Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Statements of Shareholders??? Deficit (unaudited) Sheet http://aurasystems.com/role/ShareholdersEquityType2or3 Condensed Statements of Shareholders??? Deficit (unaudited) Statements 6 false false R7.htm 006 - Disclosure - Nature of Operations And Summary of Significant Accounting Policies Sheet http://aurasystems.com/role/NatureofOperationsAndSummaryofSignificantAccountingPolicies Nature of Operations And Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Going Concern Sheet http://aurasystems.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 008 - Disclosure - Notes Payable Notes http://aurasystems.com/role/NotesPayable Notes Payable Notes 9 false false R10.htm 009 - Disclosure - Accrued Expenses Sheet http://aurasystems.com/role/AccruedExpenses Accrued Expenses Notes 10 false false R11.htm 010 - Disclosure - Shareholders' Equity Sheet http://aurasystems.com/role/ShareholdersEquity Shareholders' Equity Notes 11 false false R12.htm 011 - Disclosure - Related Parties Transactions Sheet http://aurasystems.com/role/RelatedPartiesTransactions Related Parties Transactions Notes 12 false false R13.htm 012 - Disclosure - Commitments & Contingencies Sheet http://aurasystems.com/role/CommitmentsContingencies Commitments & Contingencies Notes 13 false false R14.htm 013 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://aurasystems.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://aurasystems.com/role/NatureofOperationsAndSummaryofSignificantAccountingPolicies 14 false false R15.htm 014 - Disclosure - Notes Payable (Tables) Notes http://aurasystems.com/role/NotesPayableTables Notes Payable (Tables) Tables http://aurasystems.com/role/NotesPayable 15 false false R16.htm 015 - Disclosure - Accrued Expenses (Tables) Sheet http://aurasystems.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://aurasystems.com/role/AccruedExpenses 16 false false R17.htm 016 - Disclosure - Shareholders' Equity (Tables) Sheet http://aurasystems.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://aurasystems.com/role/ShareholdersEquity 17 false false R18.htm 018 - Disclosure - Going Concern (Details) Sheet http://aurasystems.com/role/GoingConcernDetails Going Concern (Details) Details http://aurasystems.com/role/GoingConcern 18 false false R19.htm 019 - Disclosure - Notes Payable (Details) Notes http://aurasystems.com/role/NotesPayableDetails Notes Payable (Details) Details http://aurasystems.com/role/NotesPayableTables 19 false false R20.htm 020 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction Notes http://aurasystems.com/role/ScheduleofnonrelatedpartyandrelatedpartynotespayabletransactionTable Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction Details http://aurasystems.com/role/NotesPayableTables 20 false false R21.htm 021 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) Notes http://aurasystems.com/role/ScheduleofnonrelatedpartyandrelatedpartynotespayabletransactionTable_Parentheticals Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) Details http://aurasystems.com/role/NotesPayableTables 21 false false R22.htm 022 - Disclosure - Accrued Expenses (Details) Sheet http://aurasystems.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://aurasystems.com/role/AccruedExpensesTables 22 false false R23.htm 023 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses Sheet http://aurasystems.com/role/ScheduleofaccruedexpensesTable Accrued Expenses (Details) - Schedule of accrued expenses Details http://aurasystems.com/role/AccruedExpensesTables 23 false false R24.htm 024 - Disclosure - Shareholders' Equity (Details) Sheet http://aurasystems.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://aurasystems.com/role/ShareholdersEquityTables 24 false false R25.htm 025 - Disclosure - Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date Sheet http://aurasystems.com/role/ScheduleoffairvalueofthestockoptionsasofthegrantdateTable Shareholders' Equity (Details) - Schedule of fair value of the stock options as of the grant date Details http://aurasystems.com/role/ShareholdersEquityTables 25 false false R26.htm 026 - Disclosure - Shareholders' Equity (Details) - Schedule of stock options outstanding Sheet http://aurasystems.com/role/ScheduleofstockoptionsoutstandingTable Shareholders' Equity (Details) - Schedule of stock options outstanding Details http://aurasystems.com/role/ShareholdersEquityTables 26 false false R27.htm 027 - Disclosure - Shareholders' Equity (Details) - Schedule of stock option exercisable Sheet http://aurasystems.com/role/ScheduleofstockoptionexercisableTable Shareholders' Equity (Details) - Schedule of stock option exercisable Details http://aurasystems.com/role/ShareholdersEquityTables 27 false false R28.htm 028 - Disclosure - Shareholders' Equity (Details) - Schedule of issued and outstanding warrants Sheet http://aurasystems.com/role/ScheduleofissuedandoutstandingwarrantsTable Shareholders' Equity (Details) - Schedule of issued and outstanding warrants Details http://aurasystems.com/role/ShareholdersEquityTables 28 false false R29.htm 029 - Disclosure - Shareholders' Equity (Details) - Schedule of warrants outstanding and exercisable Sheet http://aurasystems.com/role/ScheduleofwarrantsoutstandingandexercisableTable Shareholders' Equity (Details) - Schedule of warrants outstanding and exercisable Details http://aurasystems.com/role/ShareholdersEquityTables 29 false false R30.htm 030 - Disclosure - Related Parties Transactions (Details) Sheet http://aurasystems.com/role/RelatedPartiesTransactionsDetails Related Parties Transactions (Details) Details http://aurasystems.com/role/RelatedPartiesTransactions 30 false false R31.htm 031 - Disclosure - Commitments & Contingencies (Details) Sheet http://aurasystems.com/role/CommitmentsContingenciesDetails Commitments & Contingencies (Details) Details http://aurasystems.com/role/CommitmentsContingencies 31 false false All Reports Book All Reports ausi-20210531.xml ausi-20210531.xsd ausi-20210531_cal.xml ausi-20210531_def.xml ausi-20210531_lab.xml ausi-20210531_pre.xml http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true ZIP 47 0001213900-21-037022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-037022-xbrl.zip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end

Shareholders' Equity (Details) - Schedule of issued and outstanding warrants	3 Months Ended
	May 31, 2021 $ / shares shares
Schedule of issued and outstanding warrants [Abstract]
Number of Warrant, Outstanding beginning balance \| shares	5,662,272
Exercise Price, Outstanding beginning balance \| $ / shares	$ 1.40
Number of Warrant, Granted \| $ / shares
Exercise Price, Granted \| shares
Number of Warrant, Exrecised \| shares
Exercise Price, Exrecised \| $ / shares
Number of Warrant, Cancelled \| shares
Exercise Price, Cancelled \| $ / shares
Number of Warrant, Outstanding ending balance \| shares	5,662,272
Exercise Price, Outstanding ending balance \| $ / shares	$ 1.40